Statistical methods for analyzing sequencing data with applications in modern biomedical analysis and personalized medicine by Manimaran, Solaiappan
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2017
Statistical methods for analyzing
sequencing data with applications
in modern biomedical analysis and
personalized medicine
https://hdl.handle.net/2144/20879
Boston University
BOSTON UNIVERSITY 
 
GRADUATE SCHOOL OF ARTS AND SCIENCES 
 
 
 
 
 
Dissertation 
 
 
 
 
STATISTICAL METHODS FOR ANALYZING SEQUENCING DATA  
 
WITH APPLICATIONS IN MODERN BIOMEDICAL ANALYSIS AND 
 
 PERSONALIZED MEDICINE  
 
 
 
by 
 
 
 
 
SOLAIAPPAN MANIMARAN 
 
B.Sc., Indian Institute of Technology, Kharagpur, 1995 
M.E., Indian Institute of Science, Bangalore, 1999 
M.B.A., University of Connecticut, 2012 
M.A., Boston University, 2014 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Doctor of Philosophy 
 
2017  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2017 
 SOLAIAPPAN MANIMARAN 
 All rights reserved  
Approved by 
 
 
 
 
 
First Reader _________________________________________________________ 
 W. Evan Johnson, Ph.D. 
 Associate Professor of Medicine and Biostatistics 
 
 
Second Reader _________________________________________________________ 
 Paola Sebastiani, Ph.D. 
 Professor of Biostatistics 
 
 
Third Reader _________________________________________________________ 
 Josée Dupuis, Ph.D. 
 Professor of Biostatistics 
 
 
  
  iv 
DEDICATION 
 
 
 
 
I would like to dedicate this work to my mother Kanthimathi and father Solaiappan, and 
my wife Nivetha and my wonderful daughter Shwetha. 
  
  v 
ACKNOWLEDGMENTS 
First and foremost, I am extremely grateful to my advisor Dr. Evan Johnson for his 
guidance throughout my PhD program. He has advised me on all aspects of my career at 
Boston University and beyond. I cannot thank him enough for all that I could achieve in 
my career. I would like to thank my thesis committee members Dr. Paola Sebastiani, Dr. 
Josée Dupuis, Dr. Ching-Ti Liu and Dr. Stefano Monti for critical review of my thesis 
related documents and presentations and for their constant support and encouragement to 
complete my PhD program successfully.  I would like to thank Johnson’s lab current 
members Supriya, Tyler, David and Yuqing, and former members Changjin, Ying and 
Bing for their support and encouragement. I would like to thank all of our collaborators 
Keith Crandall, Eduardo Castro Nallar, Allyson Byrd, Joe Perez-Rogers, Jeffrey Leek, 
Claire Ruberman, Hector Corrada Bravo, Kwame Okrah, Alice H. Lichtenstein, Nirupa 
R. Matthan, Anne Kane, Owen Francis and Matthew Bendall.  I would like to thank all 
Computational Biomedicine friends for all the CBM meeting presentations and feedback. 
I would like to thank all my friends from the Biostatistics department for group studies 
during the coursework and would like to especially thank Avery, Revathi, Pranab and 
Dan for group studies during qualifying exams. I would like to thank all of the 
administrative staff and especially Marisa for support. I would like to thank my brothers 
Thirumani, Manikandan and Manikumar, my mother-in-law Jeevarekha  and father-in-
law Murugesh for their love and support. Finally, last but not the least, I would like to 
thank and dedicate this dissertation to my mother Kanthimathi, father Solaiappan, wife 
Nivetha and daughter Shwetha for their kind love and support for ever.  
  vi 
 
STATISTICAL METHODS FOR ANALYZING SEQUENCING DATA WITH 
APPLICATIONS IN MODERN BIOMEDICAL ANALYSIS AND 
PERSONALIZED MEDICINE 
 
SOLAIAPPAN MANIMARAN 
Boston University Graduate School of Arts and Sciences, 2017 
Major Professor: W. Evan Johnson, Associate Professor of Medicine and Biostatistics 
 
ABSTRACT 
  
  There has been tremendous advancement in sequencing technologies; the rate at 
which sequencing data can be generated has increased multifold while the cost of 
sequencing continues on a downward descent. Sequencing data provide novel insights 
into the ecological environment of microbes as well as human health and disease status 
but challenge investigators with a variety of computational issues. This thesis focuses on 
three common problems in the analysis of high-throughput data. The goals of the first 
project are to (1) develop a statistical framework and a complete software pipeline for 
metagenomics that identifies microbes to the strain level and thus facilitating a 
personalized drug treatment targeting the strain; and (2) estimate the relative content of 
microbes in a sample as accurately and as quickly as possible.  
The second project focuses on the analysis of the microbiome variation across 
multiple samples. Studying the variation of microbiomes under different conditions 
within an organism or environment is the key to diagnosing diseases and providing 
  vii 
personalized treatments. The goals are to (1) identify various statistical diversity 
measures; (2) develop confidence regions for the relative abundance estimates; (3) 
perform multi-dimensional and differential expression analysis; and (4) develop a 
complete pipeline for multi-sample microbiome analysis.  
The third project is focused on batch effect analysis. When analyzing high 
dimensional data, non-biological experimental variation or “batch effects” confound the 
true associations between the conditions of interest and the outcome variable. Batch 
effects exist even after normalization. Hence, unless the batch effects are identified and 
corrected, any attempts for downstream analyses, will likely be error prone and may lead 
to false positive results. The goals are to (1) analyze the effect of correlation of the batch 
adjusted data and develop new techniques to account for correlation in two step 
hypothesis testing approach; (2) develop a software pipeline to identify whether batch 
effects are present in the data and adjust for batch effects in a suitable way.  
In summary, we developed software pipelines called PathoScope, PathoStat and 
BatchQC as part of these projects and validated our techniques using simulation and real 
data sets. 
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CHAPTER ONE 
Introduction 
There has been tremendous recent advancement in sequencing technologies; the 
rate at which sequencing data can be generated has increased multifold while the cost of 
this sequencing continues on a downward descent. Sequencing data provide novel 
insights into the ecological environment of microbes as well as human health and disease 
status.  
This thesis focuses on three common problems in the analysis of high-throughput 
data, which are addressed by the three projects here. The first project is on methods and 
software for complete single-sample metagenomic analysis and we developed a software 
pipeline called PathoScope as part of this project. The second project develops a toolkit 
for microbiome variation analysis and we developed a R shiny app package called 
PathoStat as part of this project. The third project focuses on batch effects analysis and 
we developed a R shiny app package called BatchQC as part of this project. 
Any sample that is collected from an environment of microbes will contain a 
multitude of microbes at different proportions. Metagenomics is the study of genomic 
data, usually sequencing data, from these samples, typically with the goal of 
characterizing the microbial communities present in the sample. Although many tools 
have emerged for analyzing metagenomic-sequencing data, these existing methods are 
often not efficient and or may have low specificity. These tools usually do not include a 
complete metagenomic data analysis framework. The goals of the first project are (1) to 
develop a statistical framework and a complete software pipeline for metagenomic 
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analysis of next-generation sequencing data that identifies microbes and pathogens to the 
strain level; (2) to estimate the relative content of pathogens and benign microbial flora in 
a sample as accurately as possible, while developing tools that can analyze massive 
amounts of data in a short timeframe. Broadly, the project is structured into the following 
aims: A) Determine how accurately microbial proportions can be estimated when there is 
a mixture of multiple microbes with varying proportions in the sample. A Bayesian 
mixture modeling approach generally works best in this context because it can integrate 
information across all genomes and converges to a solution quickly using an expectation 
maximization algorithm. The aim is to evaluate the accuracy of the Bayesian mixture 
modeling approach in comparison to other methods and also to evaluate how prior 
information in the Bayesian mixture modeling affects (or improves) these estimates. B) 
Evaluate how many sequencing reads are needed (read coverage) to estimate pathogen 
proportions to a given confidence limit, and determine how long it takes to estimate 
microbial proportions within a given confidence limits using our mixture model and in 
comparison to other methods. C) Develop a complete software pipeline, PathoScope, for 
metagenomics analysis of next-generation sequencing data. 
The microbiome can vary significantly between different biological conditions 
such as disease status or treatment differences or other covariates of interest within an 
organism or environment. Studying the variation of microbiomes under different 
conditions within an organism or environment is the key to diagnosing diseases and 
providing personalized treatments. For the second project, the goals are the following: A) 
Identify various statistical measures such as alpha and beta diversity for characterizing 
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the microbiome variation under different conditions and develop a module for 
visualization of the statistical measures; B) Develop a module to calculate and display the 
confidence regions for the relative abundance estimates; C) Perform Multi-dimensional 
and differential expression analysis of microbiomes under various conditions of interest; 
D) Develop a software pipeline called PathoStat for Microbiome variation analysis. 
When analyzing high dimensional data, non-biological experimental variation or 
“batch effects” confound the true associations between the conditions of interest and the 
outcome variable. As shown in the Figure 1 of the nature review article (Leek, Scharpf, 
Bravo et al., 2010), batch effects exist even after normalization. Hence, unless the batch 
effects are identified and removed, any attempts for downstream analyses, such as 
network inference and estimation, will likely be error prone and may lead to false 
positive results. Furthermore, many batch adjustment approaches artificially induce a 
correlation structure in the batch adjusted data that can often exaggerate the significance 
of results (e.g. p-values) or even introduce spurious relationships in the data. This 
motivates the need for a computational framework to systematically identifying batch 
effects. Here, the aim is to develop a tool called BatchQC that visually depicts aspects of 
high dimensional data and evaluates the extent to which batch effects impact the 
association between the conditions of interest. Broadly, the aims of the third project are to 
do the following: A) Analyze the effect of correlation of the batch adjusted data and 
develop new techniques to account for correlation in two step hypothesis testing 
approach. B) Develop a software pipeline called BatchQC to identify whether batch 
effects are present in the data and adjust for batch effects in a suitable way.  
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 The three projects together provide a complete set of toolkits and 
methodology necessary for analysis of genomic data for these applications. In particular, 
the PathoScope toolkit is useful during a new outbreak situation and helps in identifying 
the particular strain of the pathogen causing the outbreak and thereby facilitating a 
personalized treatment plan targeting the particular strain of the pathogen. The PathoStat 
toolkit for microbiome variation analysis is useful in studying the microbiome variations 
associated with various diseases such as skin disease (Speeckaert, Lambert, Grine et al., 
2016), celiac disease (Harnett, Myers & Rolfe, 2016; Leonard & Fasano, 2016; Scher, 
2016) and gastrointestinal cancer (Wroblewski, Peek & Coburn, 2016). When performing 
multi-dimensional and differential expression analysis using genomic data, often times 
they are affected by technical variation attributable to both observed and unobserved 
factors (Leek et al., 2010) and BatchQC can help to identify whether batch effects are 
present in the data and adjust for batch effects in a suitable way. We hope that these 
toolkits and methodology developed as part of these projects is of tremendous help to the 
scientific community in performing genomic data analysis.  
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CHAPTER TWO 
Project 1: Methods and Software for Complete Metagenomic Analysis 
Introduction 
Metagenomics is the study of genomic data, usually sequencing data, typically 
with the goal of characterizing the microbial communities present in the sample. 
Although many tools have emerged for analyzing metagenomic-sequencing data, these 
existing methods are often not efficient and or may have low specificity. These tools 
usually do not include a complete metagenomic data analysis framework. The goals of 
this project are (1) to develop a statistical framework and a complete software pipeline 
for metagenomic analysis of next-generation sequencing data that identifies microbes and 
pathogens to the strain level; (2) is to estimate the relative content of pathogens and 
benign microbial flora in a sample as accurately as possible, while developing tools that 
can analyze massive amounts of data in a short timeframe. Broadly, the project is 
structured into the following aims: A) Determine how accurately microbial proportions 
can be estimated when there is a mixture of multiple microbes with varying proportions 
in the sample. A Bayesian mixture modeling approach generally works best in this 
context because it can integrate information across all genomes and converges to a 
solution quickly using an expectation maximization algorithm. The aim is to evaluate the 
accuracy of the Bayesian mixture modeling approach in comparison to other methods and 
also to evaluate how prior information in the Bayesian mixture modeling affects (or 
improves) these estimates. B) Evaluate how many sequencing reads are needed (read 
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coverage) to estimate pathogen proportions to a given confidence limit, and determine 
how long it takes to estimate microbial proportions within a given confidence limits using 
our mixture model and in comparison to other methods. C) Develop a complete software 
pipeline, PathoScope, for metagenomics analysis of next-generation sequencing data. 
   
Metagenomic Analysis 
The primary initial analysis goal for each sample from a metagenomics study is to 
identify the microbes present and also to quantify the exact proportion of each of the 
microbes in a sample. 
 
Before the introduction of our PathoScope approach, one or more of the following 
three general approaches were most common for metagenomic analysis: 1) composition 
or pattern matching (Wood & Salzberg, 2014; Segata, Waldron, Ballarini et al., 2012; 
Brady & Salzberg, 2009; McHardy, Martin, Tsirigos et al., 2007), 2) taxonomic mapping 
(Patil, Roune & McHardy, 2012; Segata et al., 2012; Gerlach & Stoye, 2011; Monzoorul 
Haque, Ghosh, Komanduri et al., 2009; Meyer, Paarmann, D'Souza et al., 2008; Huson, 
Auch, Qi et al., 2007), and 3) whole genome assembly (Bhaduri, Qu, Lee et al., 2012; 
Kostic, Ojesina, Pedamallu et al., 2011). 
 In composition and pattern matching algorithms, pre-determined patterns in the 
data, such as taxonomic clade markers (Segata et al., 2012), k-mer frequency and GC 
content  along with classification algorithms such as support vector machines (Patil et al., 
2012; McHardy et al., 2007) or interpolated Markov Models (Brady & Salzberg, 2009) 
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are used to classify reads to the species of interest. Often times, these approaches require 
a huge amount of preprocessing to be done on the genomic database before they can be 
applied and the results of these methods can also vary based on the size and composition 
of the genome database.  
 
In taxonomy based approaches, the most specific taxonomic group for each read 
is identified and they are also called the “lowest common ancestor” approach (Huson et 
al., 2007). In this approach, reads are assigned to the lowest taxonomic group that 
contains all the genomes with which the reads share homologous regions. While these 
methods are very accurate for higher-level taxonomic levels (e.g. phylum and family), 
they are not very accurate for lower levels (e.g. species and strain) (Gerlach & Stoye, 
2011). These approaches fail to identify the specific species or strains in the sample, 
particularly when the reads originate from a strain that is closely related to another one in 
the database, but rather maps the reads to higher-level taxonomies, which is not very 
informative.  
 
Assembly-based algorithms can accurately identify to the strain level, but these 
methods are time consuming requiring the construction of a whole genome. They are also 
computationally difficult and require large numbers of reads in the order of 50-100X 
coverage of the target genome to achieve an adequate accuracy (Schatz, Delcher & 
Salzberg, 2010). For purified samples, the current sequencing depths level of coverage is 
usually sufficient, but for mixed samples or in multiplex sequencing runs, the level of 
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coverage is usually not sufficient. These assembly approaches also require multiple 
filtering and alignment steps to obtain reads specific to the pathogen of interest, when 
data collection at a crime scene or hospital include additional environmental components 
such as host genome or naturally occurring bacterial and viral species. 
 
Here, we describe our PathoScope computational framework for strain 
identification in environmental or clinical sequencing samples to analyze next-generation 
sequence data. PathoScope consists of  four core modules namely PathoLib, PathoMap, 
PathoID and PathoReport, and two optional modules namely PathoDB (database to store 
detailed information about the reference sequences) and PathoQC (quality control of 
input read sequences).  PathoLib is a module for generating custom reference genome 
libraries. PathoMap is a module for aligning reads to the target reference library and filter 
out any reads that aligns better to filter reference library. PathoID is a module that utilizes 
a modified pseudo likelihood model based on a Bayesian modeling framework (Francis, 
Bendall, Manimaran et al., 2013) for reassigning all ambiguous reads to the most likely 
source genome in the reference library.  PathoReport is a module for generating a report 
in TSV (Tab Separated Value) format from the alignment file generated by PathoMap 
after reassignment processing by PathoID.  Our PathoID reassignment approach 
accommodates information on mapping quality, read length and provides posterior 
probabilities of matches to a known database of reference genomes. Importantly, our 
PathoID approach incorporates the possibility that multiple species can be present in the 
sample or that the target strain is not even contained within the reference database. It also 
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accurately discriminates between very closely related strains of the same species with 
much less than 1X coverage of the genome and without the need for sequence assembly 
or complex preprocessing of the database or taxonomy. No other method in the literature 
can identify species or substrains in such a direct and automatic manner and without the 
need for large numbers of reads. We later describe in detail two versions of PathoID 
(versions 1.0 and 2.0) which have the same base statistical model, but differ in the way 
the data they input and handle aligned sequencing data, and PathoID 2.0 has more 
flexibility in prior parameter selection. Specifically, in PathoID version 1.0, we used 
SAM -MAPQ  (https://samtools.github.io/hts-specs/SAMv1.pdf) score to provide relative 
alignment probabilities. MAPQ score is used to capture the goodness of mapping, which 
equals −10 log10 Pr(mapping position is wrong), rounded to the nearest integer. It is 
essentially a metric that measures the likelihood that a read comes from the reported 
position. In PathoID 2.0, we use the read alignment bit score (AS) from the Bowtie2 
(Langmead & Salzberg, 2012) output. An alignment score quantifies how similar the read 
sequence is to the reference sequence aligned to. The higher the score, the more similar 
they are. A score is calculated by subtracting penalties for each difference (mismatch, 
gap, etc) and, in local alignment mode, adding bonuses for each match. The scores can be 
configured with the --ma (match bonus), --mp (mismatch penalty), --np (penalty for 
having an N in either the read or the reference), --rdg (affine read gap penalty) and --rfg 
(affine reference gap penalty) options.(http://bowtie-
bio.sourceforge.net/bowtie2/manual.shtml#scores-higher-more-similar). In PathoID 2.0 
the AS is also standardized by adding the read length and normalizing the score (Hong, 
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Manimaran, Shen et al., 2014b). PathoID 2.0 also has an option to accept a more varied 
selection of prior parameters  for the Bayesian model. More details about the PathoScope 
modules are provided later in this chapter. 
 
Aim 1A 
Accurately estimate microbial proportions, using a Bayesian mixture modeling 
approach, when there is a mixture of multiple microbes with varying proportions in the 
sample. We will also evaluate how prior information in the Bayesian mixture modeling 
affects (or improves) these estimates. 
Objective 
Use in silico mixtures of microbial reads from biological isolates using varying 
proportions of microbes present in each of the samples. Study the accuracy of the 
metagenomic estimates for different cases using a Bayesian mixture modeling approach 
with different priors and parameterizations. 
Rationale 
When pathogens are present in equal proportions in a sample or if the aim is 
merely to detect the presence of pathogens, there are several sequence aligners available, 
such as Bowtie2 (Langmead & Salzberg, 2012) or BLAST (Altschul, Madden, Schaffer 
et al., 1997), to accomplish this task. In a sample with many sequencing reads, there will 
be some reads (often a small proportion) that will uniquely align to the reference 
genomes of some of the pathogens present in the sample, and the aligners can simply 
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detect those pathogens. However, when the pathogens are present in varying proportions, 
it is very difficult to estimate the proportions of each of the pathogens accurately. 
Reassignment of reads aligned by these aligners to the correct pathogens using Bayesian 
mixture models have the potential to outperform other methods both in accuracy and 
speed, but no one has conducted a formal evaluation of these tools. Hence, a study to 
estimate the accuracy of the Bayesian mixture model approach when there is a mixture of 
multiple pathogens with varying proportions is very important to establish the efficacy of 
the method.  
Experimental Setup 
Samples are simulated by mixing reads in silico from pathogens in different 
proportions. As an example, we selected reads from three different bacterial strains, with 
sequencing data from experimental or clinical isolates, that are available from the NCBI 
Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra). We collected reads 
from the Y. pestis KIM D27 (SRR032501), E. coli K-12 MG1655 (SRR031601), and F. 
tularensis subsp. holarctica  OSU18 (SRR032505) data sets. All of these reads were 
sequenced using the 454 platform (Roche). These data sets consisted of 318332, 143836 
and  28221 reads respectively. Read lengths typically range from 77 to 277 base pairs. 
We picked a maximum of 5770 reads from each of the data sets based on the lowest 
number of mapped reads available in the F. tularensis dataset, and mixed them in 
different proportions to form 1000 samples.  
For another thorough validation of the method, we simulated reads from 25 
strains of bacteria, at different proportions. These 25 strains including five closely related 
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Escherichia coli substrains, five closely related Staphylococcus aureus substrains, five 
closely related Streptococcus pneumoniae substrains and 10 other commonly occurring 
human bacterial strains that are more distantly to each other and the other strains in the 
sample. We estimated pathogen proportions using our PathoID Bayesian mixture model 
with different parameterizations and priors and used the true proportions to establish the 
efficacy of the method. 
 
Analysis Plan 
The effect of different prior parameters, read lengths and quality of the samples 
on the pathogens proportions estimate of the Bayes mixture model for different samples 
with varying proportions of closely related and unrelated mixture of pathogens will be 
analyzed. Read lengths and a weighted alignment score will be incorporated in the 
likelihood calculation of the Bayes mixture model and choose the best alignment 
parameters to use for samples generated from different sequencing platforms. 
Two Component Mixture Model 
In the context of a simple mixture model, let Y be a mixture of two distributions  
𝑌1 ~ ∅𝜃1(𝑦) and 𝑌1 ~ ∅𝜃2(𝑦) with 𝑋 𝑢𝑢𝑢𝑢𝑢𝑢𝑢 𝑎𝑢𝑎 𝑋 ~ 𝐵𝐵𝐵𝑢𝑢𝑢𝐵𝐵𝐵(𝜋) as follows: 
𝑌 = (1 − 𝑋)𝑌1 + 𝑋𝑌2 
𝑋 ∈ [0,1] 
Then the marginal distribution of Y based on the observed data, integrating out 
the missing data is the following: 
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𝑔𝑌(𝑦) = (1 − 𝜋)∅𝜃1(𝑦) +  𝜋∅𝜃2(𝑦) Pr(𝑋 = 1) =  𝜋 
We will let 𝜃 = (𝜋,𝜃1, 𝜃2) represent the parameters of this model. 
The log-likelihood based on N training cases of data Z is: 
𝐵(𝜃;𝑍) =  �𝐵𝑢𝑔�(1 − 𝜋)∅𝜃1(𝑦𝑖) +  𝜋∅𝜃2(𝑦𝑖)�𝑁
𝑖=1
 
Direct maximization of 𝐵(𝜃;𝑍) is quite difficult. Instead, we use the unobserved 
latent variable ∆𝑖 and represent the complete data (observed data plus missing data) 
likelihood equivalently but more conveniently as follows.  
𝐿(𝜃;𝑍,𝑋) =  ���∅𝜃1(𝑦𝑖) 𝜋�(1−𝑋𝑖)�∅𝜃2(𝑦𝑖) (1 − 𝜋)�𝑋𝑖�𝑁
𝑖=1
 
Then the complete data log-likelihood function would be given as follows. 
𝐵(𝜃;𝑍,𝑋) =  ��(1 − 𝑋𝑖)𝐵𝑢𝑔 ∅𝜃1(𝑦𝑖) +  𝑋𝑖𝐵𝑢𝑔∅𝜃2(𝑦𝑖)�𝑁
𝑖=1
+  �[(1 − 𝑋𝑖)𝐵𝑢𝑔 𝜋 +  𝑋𝑖log (1 − 𝜋)]𝑁
𝑖=1
 
We use the Expectation Maximization (EM) algorithm (Dempster, 1977) to 
effectively impute the missing data and estimate the model parameters. Because the log-
likelihood is linear in the missing data, the E-step reduces to computing the expected 
values of 𝑋𝑖 given the current values of the model parameters 𝜃 (using reasonable starting 
values for initiation), 𝛿𝑖(𝜃) =  𝐸(𝑋𝑖|𝜃,𝑍) =  Pr(𝑋𝑖 = 1|𝜃,𝑍), and inserting these 
expectations into the log-likelihood. The M-step then consists of computing 𝜃 that 
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maximizes the complete data log likelihood using the imputed missing data. The E- and 
M- steps are then iterated to convergence. This EM approach has been shown to be 
equivalent to maximizing the parameters over the marginal likelihood of the observed 
data given above (Hastie, Tibshirani & Friedman, 2009). 
Bayesian Mixture Model 
Now we extend the simple two component mixture model to Bayesian Mixture 
model. To formally describe the Bayesian Mixture model, let i=1,...,R be the index of the 
reads and let j=1,...,G be the index of the genomes in the database. Let 
xi=(xi1,xi2,...,xiG)=[xij] be a set of genome indicators for read i  where xij=1 if the read 
originated from the jth genome and xij=0 if the read did not come from genome j. Note 
that by assumption one and only one element in the vector xi can be equal to 1 (i.e. each 
read has only one template genome). It is assumed that xi follows a multinomial 
distribution, with probability of success π=(π1,π2,...,πG)=[πj] where πj is the proportion of 
the reads that originated from the jth genome. 
Likelihood model 
For the Likelihood model, as we have seen in the simple two component mixture 
model, it is difficult to perform the direct maximization of the likelihood based on the 
observed data. For those reads that are uniquely mapped, the likelihood is directly known, 
but for those reads that are not mapped uniquely, we use a penalized mixture model that 
penalizes the likelihood contributions from reads that map to multiple genomes, and thus 
relies more heavily on reads that align to only one genome. To facilitate the penalty on 
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the multi-map reads, let us define yi as the uniqueness indicator for read i, namely letting 
yi=1 if read i uniquely maps to one genome and yi=0 otherwise. We also define a second 
set of parameters, θ=(θ1,θ2,...,θG)=[θj] to represent the multinomial distribution that yi is 
assumed to follow. For the unique reads, we directly observe the genome indicator xi. For 
the non-unique reads, the genome indicator xi is unobserved or missing data and the 
observations are partial mapping qualities for each of the genomes. Alignment programs 
Bowtie2 (Langmead & Salzberg, 2012) and BLAST (Altschul et al., 1997) reports a 
score for the goodness of the alignment of the read with each of the genomes. In general, 
many read alignment approaches use some variant of a Smith-Waterman algorithm 
(Durbin, Eddy, Krogh et al., 1998). These algorithms employ dynamic programing 
approaches to identify the optimal sequence alignment between two nucleic acid or 
protein sequences. To summarize succinctly, assume the following simple scoring 
function for an alignment of two sequences: +2 for each base/peptide matched in the 
alignment, +1 for each base/peptide mismatched, and 0 for each gap inserted into the 
alignment, and then are summed to generate an individual score, r, for each proposed 
alignment. Then for example, aligning the nucleic acid sequence ‘AGTAGAC’ to 
‘ATACGA’ has an optimal alignment of:  
AGTA-GAC 
| || | | 
A-TACG-A 
 
Which has an alignment score of r=9 (four matches, one mismatch, three gaps). 
The Smith-Waterman dynamic programming algorithm can be used to identify the best 
possible local alignment (optimal r) in an efficient way (Durbin et al., 1998). Note that in 
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these algorithms, the exponentiated alignment score, q=er, can have a likelihood 
interpretation. Namely, we assume that each sequence position in the alignment is i.i.d. 
and follows a multinomial distribution with three choices, match, mismatch, and gap, 
with the selected scoring function determining the multinomial probabilities. Now, 
extending this likelihood interpretation to the case of aligning reads to multiple genomes, 
the exponentiated alignment score of read i to genome j, denoted qij, be interpreted as the 
relative likelihood that read i originated from genome j. BLAST and Bowtie2 use 
heuristic simplifications of the Smith-Waterman to calculate read scores and attempt to 
find the best alignments. Although these algorithms are not guaranteed to find the optimal 
sequence alignment, but usually do find the best-scoring alignment and do so in a manner 
that is computationally efficient, often orders of magnitude faster than the much slower 
Smith-Waterman. For this reason, we will use these algorithms and assume that the 
alignments produced represent all optimal and suboptimal alignment possibilities, and the 
exponetiated BLAST, Bowtie2 or (unexponentiated) MAPQ scores represent relative 
likelihood alignment scores, qij,  to be used in the mixture model below.  
 In PathoID 2.0, we use the relative likelihood mapping scores described later in 
the Modified Pseudo Likelihood model section and denoted by qi=(qi1,qi2,...,qiG)=[qij]. 
For unique reads, the qij values are equal to the xij values. For non-unique reads, the 
mapping scores represent the uncertainty in mapping and need to be rescaled—or 
equivalently these reads need to be reassigned to the correct template genome of origin. 
In order to do this, we use the parameters θ=(θ1,θ2,...,θG)=[θj] for performing the 
reassignment and here θj parameter represents the proportion of the non-unique reads that 
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need to be reassigned to the jth genome. The complete data likelihood of the parameters 
(π, θ) given the observed data (reads mapping quality qij, yi, unique xi) and the missing 
data (non-unique xi) is calculated as follows:  
The unconditional distribution of xi is given by the following multinomial distribution: 
𝑓(𝑥𝑖|𝜋) =  � 𝜋𝑗𝑥𝑖𝑖𝐺
𝑗=1
 
Since xi is not observed, we cannot directly compute the likelihood L(π|xi) and we can 
instead compute the conditional likelihood given the observed data yi and qi, where qi is 
the quality score. 
𝑓(𝑥𝑖, 𝑦𝑖|𝜋,𝜃, 𝑞𝑖) =  𝑓(𝑥𝑖|𝑦𝑖,𝜋,𝜃, 𝑞𝑖)𝑓(𝑦𝑖|𝜋, 𝜃, 𝑞𝑖) 
𝑓(𝑥𝑖,𝑦𝑖|𝜋, 𝜃, 𝑞𝑖) = �� 𝜋𝑗𝑥𝑖𝑖𝐺
𝑗=1
� �� �𝜃𝑗
(1−𝑦𝑖) 𝑞𝑖𝑗
∑ 𝑞𝑖𝑖
𝐺
𝑖=1
�
𝑥𝑖𝑖𝐺
𝑗=1
� 
We can rewrite the above equation as follows: 
𝑓(𝑥𝑖, 𝑦𝑖|𝜋,𝜃, 𝑞𝑖) ∝ �� �𝜋𝑗𝜃𝑗(1−𝑦𝑖)𝑞𝑖𝑗�𝑥𝑖𝑖𝐺
𝑗=1
� 
Since each reads are assumed to be independent reads, we get the following . 
𝑓(𝑥,𝑦|𝜋,𝜃, 𝑞) ∝ �� � �𝜋𝑗𝜃𝑗(1−𝑦𝑖)𝑞𝑖𝑗�𝑥𝑖𝑖𝐺
𝑗=1
𝑅
𝑖=1
� 
And the likelihood is the following. L(𝛑,𝛉|𝐱𝐢,𝐪𝐢, 𝐲) ∝ ∏ ∏ [πjθj(1−yi)qij]xijGj=1Ri=1   
Although the reassigned reads (estimated xi) and reassignment parameters (estimated θ) 
are very informative, the quantities of interest from the modeling steps are the estimates 
for the genome read proportions (estimated π). These probabilities will identify the single 
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or multiple organisms from the database that are present in the samples, based on the 
proportion of the reads that are assigned to the genome after the reads are reassigned. 
Bayesian Prior Distribution 
We will assume that a priori the variables π and θ follow Dirichlet distributions, the 
densities of which can be seen in the following equations:  
𝑓(𝛑|𝐚) ∝ ∏ πjaj−1Gj=1  and 𝑓(𝛉|𝐛) ∝ ∏ θjbj−1Gj=1 . 
If aj=1 for all j=1,...,G, this is equivalent to adding one unique read for each of the G 
genomes, and aj=n would be the equivalent of adding n unique reads to the jth genome. 
Similarly, bj=n is the equivalent of adding n reads of non-unique read probabilities to the 
jth genome. In our PathoID 1.0 model, we use a non-informative prior distribution and the likelihood as described above. 
Modified Pseudo Likelihood model 
For PathoID 2.0, we develop a modified Pseudo Likelihood model that penalizes 
the likelihood based on read length and read alignment score and utilizes prior 
information about the genome proportions of different strains. In this model, the 
likelihood that read i is from genome j (qij) is constructed as a normalized score of the 
sum of read alignment score and read length as follows.  
𝑞𝑖𝑗 =  𝑠𝑖𝑗 + 𝐵𝑖∑ (𝑠𝑖𝑖 + 𝐵𝑖)𝐺𝑖=1  
𝑞𝑖𝑗: = 𝑁𝑢𝐵𝑁𝑎𝐵𝐵𝑁𝐵𝑎 𝑠𝑠𝑢𝐵𝐵 𝑡ℎ𝑎𝑡 𝐵𝐵𝑎𝑎 𝐵 𝐵𝑠 𝑓𝐵𝑢𝑁 𝑔𝐵𝑢𝑢𝑁𝐵 𝑗 
𝑠𝑖𝑗: = 𝐴𝐵𝐵𝑔𝑢𝑁𝐵𝑢𝑡 𝑠𝑠𝑢𝐵𝐵 𝑡ℎ𝑎𝑡 𝐵𝐵𝑎𝑎 𝐵 𝐵𝑠 𝑓𝐵𝑢𝑁 𝑔𝐵𝑢𝑢𝑁𝐵 𝑗 
𝐵𝑖: = 𝑅𝐵𝑎𝑎 𝐵𝐵𝑢𝑔𝑡ℎ 𝑢𝑓 𝐵𝐵𝑎𝑎 𝐵 
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This is a pseudo likelihood model because it’s a likelihood model that is 
intuitively changed so it performs better, but no longer a likelihood. PathoID 2.0 uses this 
pseudo-likelihood model, whereas PathoID 1.0 uses the actual, proper likelihood for 
reassignment. In the software implementation of PathoID 2.0, the user can easily modify 
the prior values (most importantly for θ), whereas the software for PathoID 1.0 does not 
accommodate prior values besides the built-in non-informative values. 
EM algorithm 
Estimation of the model parameters and reassignment of the reads is 
accomplished using an Expectation-Maximization (EM) algorithm (Dempster, 1977). In 
the E-step, the expected value of xi is computed for each combination of i=1,...,R and 
j=1,...,G based estimates of π and θ, as well as the observed data qi and y. In the E-step, 
the expected values of the elements of xi are estimated as follows:  
Based on the likelihood that we computed above, we get the following marginal 
distribution of 𝑥𝑖𝑗 and its expectation as follows. 
𝑓�𝑥𝐵𝑗 = 1� = 𝜋𝑗𝜃𝑗�1−𝑦𝐵�𝑞𝐵𝑗
∑ 𝜋k𝜃k�1−𝑦𝐵�𝑞𝐵k𝐺𝑢=1  
𝑓�𝑥𝑖𝑗 = 0� = 1 − 𝑓�𝑥𝑖𝑗 = 1� 
δ�𝑖𝑗 = E�𝑥𝑖𝑗� = 1.𝑓�𝑥𝑖𝑗 = 1� + 0.𝑓�𝑥𝑖𝑗 = 0� 
δ�𝑖𝑗 = E�𝑥𝑖𝑗� = 𝜋𝑗𝜃𝑗(1−𝑦𝑖)𝑞𝑖𝑗
∑ 𝜋k𝜃k
(1−𝑦𝑖)𝑞𝑖k𝐺𝑖=1  
Next, the M-step calculates the new estimates of π and θ given qi, y and the current 
expected values δ�𝑖𝑗. The formulas for estimating π and θ, provide the Bayesian maximum 
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a posteriori (MAP) estimates; however, if the prior information aj and bj are set to 0 for 
all j genomes, these equations provide the maximum likelihood estimates. Letting N = ∑ ∑ δ�𝑅𝑖=1 𝑖𝑖𝐺𝑖=1 , these estimates are as follows: 
𝑓(𝑥,𝑦,𝜋, 𝜃) =  𝑓(𝑥,𝑦|𝜋,𝜃)𝑓(𝜋,𝜃) 
From the calculation above, we have the following: 
𝑓(𝑥,𝑦|𝜋,𝜃, 𝑞) ∝ �� � �𝜋𝑗𝜃𝑗(1−𝑦𝑖)𝑞𝑖𝑗�𝑥𝑖𝑖𝐺
𝑗=1
𝑅
𝑖=1
� 
From the prior distribution, we have the following: 
𝑓(π|a) ∝ ∏ πjaj−1Gj=1  and 𝑓(θ|b) ∝ ∏ θjbj−1Gj=1  
𝑓(𝑥,𝑦,𝜋,𝜃|𝑞) ∝  �� � �𝜋𝑗𝜃𝑗(1−𝑦𝑖)𝑞𝑖𝑗�𝑥𝑖𝑖𝐺
𝑗=1
𝑅
𝑖=1
�  �πjaj−1G
j=1
 �θjbj−1G
j=1
 
The value of 𝜋 𝑎𝑢𝑎 𝜃 that maximizes the likelihood also maximizes the following: 
𝐿1 =  �� πjaj𝐺
𝑗=1
� �𝜋𝑗�
𝑥𝑖𝑖
𝑅
𝑖=1
� 
and the following: 
𝐿2 =  �� θjbj𝐺
𝑗=1
� �𝜃𝑗
(1−𝑦𝑖)�𝑥𝑖𝑖𝑅
𝑖=1
� 
We need to maximize 𝐿1 with the condition ∑ 𝜋𝑗
𝐺
𝑗=1 = 1 
𝐿1 =  �� πj∑ 𝑥𝑖𝑖+ 𝑅𝑖=1 aj𝐺
𝑗=1
� 
This reduces to solving for πj similar to the regular multinomial distribution case but δ�𝑖𝑗 
substituted for 𝑥𝑖𝑗 because 𝑥𝑖𝑗 is estimated using the EM algorithm.  
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For the regular multinomial distribution, the solution is obtained as follows: 
𝐿 =  � 𝑝𝑖𝑥𝑖𝑁
𝑖=1
 
Taking the log likelihood: 
𝐵 =  � 𝑥𝑖 log (𝑝𝑖)𝑁
𝑖=1
 
Put 𝑝𝑁 = 1 − (𝑝1 + ⋯+ 𝑝𝑁−1) in the above equation and partial differentiate w.r.t. 𝑝𝑖 
gives the following equations: 
𝑥𝑖
𝑝𝑖
−
𝑥𝑁1 − (𝑝1 + ⋯+ 𝑝𝑁−1) = 0; 𝐵 = 1 𝑡𝑢 𝑁 − 1  
Solving these equations gives: 𝑝𝚤� = 𝑥𝑖∑ 𝑥𝑖𝑁𝑖=1  
By applying the above result, the value of 𝜋�𝑗 that maximizes 𝐿1 is given by the following: 
𝜋�𝑗 = ∑ δ�𝑖𝑖+𝑎𝑖𝑅𝑖=1𝑁+∑ 𝑎𝑘𝐺𝑘=1   
Similarly, we need to maximize 𝐿2 with the condition ∑ 𝜃𝑗𝐺𝑗=1 = 1. 
𝐿2 =  �� θj∑ 𝑥𝑖𝑖+ 𝑅𝑖=1 aj𝐺
𝑗=1
� 
 The value of 𝜃�𝑗 that maximizes 𝐿2 is given by the following: 
 𝜃�𝑗 = ∑ (1−𝑦𝑖)δ�𝑖𝑖+𝑏𝑖𝑅𝑖=1∑ (1−𝑦𝑖)𝑅𝑖=1 +∑ 𝑏𝑘𝐺𝑘=1  
The E-step is then repeated using the updated estimates of π and θ followed again 
by the M-step. These steps are repeated until the expected value of xi and the estimates of 
π and θ converge to stable values across iterations. 
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The performance of the modified Pseudo Likelihood model with the Bayesian 
distribution assumption is evaluated as mentioned in the experimental plan above. 
 
Mixed Simulation: Evaluation of PathoID 1.0  
To determine the accuracy of the pathogen proportion estimate—a mixture of samples is 
simulated by mixing reads of multiple pathogens in varying proportions. Specifically, 
mixture of samples are created from Y. pestis KIM D27 (SRR033501), E. coli K-12 
MG1655(SRR031601), and F. tularensis subsp. Holarctica OSU18 (SRR032505) by 
random sampling of reads and mixed in random proportions to determine the accuracy of 
the pathogen estimation method. The Table 1 below shows the results from 1,000 random 
mixtures of approximately 5,770 reads from the Y. pestis KIM D27 (SRR033501), E. coli 
K-12 MG1655 (SRR031601) and F. tularensis subsp. holarctica OSU18 (SRR032505) 
datasets.  
First we define a naïve approach for comparison with our PathoID approach. In 
the naïve approach the estimated proportion of genomes is computed by the sum of 
alignment proportions as follows: 
𝜋𝚥� = 1𝑅  � exp (𝑎𝑖𝑗)∑ exp (𝑎𝑖𝑗)𝐺𝑗=1𝑅𝑖=1   
𝜋𝚥� : = 𝐸𝑠𝑡𝐵𝑁𝑎𝑡𝐵𝑎 𝑝𝐵𝑢𝑝𝑢𝐵𝑡𝐵𝑢𝑢 𝑢𝑓 𝑔𝐵𝑢𝑢𝑁𝐵 𝑗 
𝑎𝑖𝑗: = 𝐴𝐵𝐵𝑔𝑢𝑁𝐵𝑢𝑡 𝑏𝐵𝑡 𝑠𝑠𝑢𝐵𝐵 (𝐴𝐴) 𝑡ℎ𝑎𝑡 𝐵𝐵𝑎𝑎 𝐵 𝐵𝑠 𝑓𝐵𝑢𝑁 𝑔𝐵𝑢𝑢𝑁𝐵 𝑗 
𝑅: = 𝑇𝑢𝑡𝑎𝐵 𝑢𝑢𝑁𝑏𝐵𝐵 𝑢𝑓 𝐵𝐵𝑎𝑎𝑠 
𝐺: = 𝑇𝑢𝑡𝑎𝐵 𝑢𝑢𝑁𝑏𝐵𝐵 𝑢𝑓 𝑔𝐵𝑢𝑢𝑁𝐵𝑠 
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The proportion estimates from the naïve approach (Bowtie 2 with default 
parameters) were extremely biased, typically underestimating the true read proportion, 
while PathoID 1.0 estimated the true proportions with high precision.  In addition, the 
naïve approach (Bowtie 2) consistently ranked genomes in the sample lower than many 
genomes that were not in the sample. PathoID 1.0 performed very well in these 
comparisons with high precision on species proportions and consistently correct genome 
ranking. However, PathoID 1.0 did fail to identify the E. coli substrain in some of the 
samples—in these cases, PathoID 1.0 identified a nearly identical K12 substrain (~25 
base differences in 5 million base genomes) or split the reads between the three K12 
substrains in the database.   
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Organism 
Naïve 
Mapping 
(Bowtie 2) 
PathoID 1.0 
Average Absolute Difference         Y. pestis KIM D27 0.3160 0.0008 
        E. coli K-12 MG1655 0.3073 0.0092 
        F. tularensis subsp. holarctica OSU18 0.2708 0.0038 
Average Ranking (among 131 full genomes)         Y. pestis KIM D27 13.1 2.0 
        E. coli K-12 MG1655 7.4 2.2 
        F. tularensis subsp. holarctica OSU18 4.4 2.0 
Number of Times Not Ranked in Top 3 (not in Top 10)         Y. pestis KIM D27 964 (627) 4 (0) 
        E. coli K-12 MG1655 613 (140) 67 (1) 
        F. tularensis subsp. holarctica OSU18 311 (79) 1 (0) 
 
Table 1: Mixed Proportion Simulation results 
 
Results from 1000 random mixtures of ~5770 reads from the Y. pestis KIM D27 (SRR033501), E. coli K-12 MG1655 (SRR031601), and F. tularensis subsp. holarctica OSU18 (SRR032505) data sets. The naïve mapping here is done by Bowtie 2 with default parameters. Average absolute difference represents the average of the absolute difference between the true proportion and the estimated proportion. PathoID 1.0 has average absolute difference close to zero and the average rank close to 2 as expected when there is a mixture of three genomes, indicating very good performance. And the number of times PathoID 1.0 has not ranked the three genomes in the top three is very low indicating very good performance in comparison to naïve mapping. 
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Equal Proportion Simulation Study: Comparing PathoID 1.0 vs 2.0 and sensitivity of 
PathoID 2.0 to different prior θ values 
We simulated sequencing reads from 25 strains of bacteria which includes five 
Escherichia coli strains (O42, 55989, SE11, SE15 UMNK88), five Staphylococcus 
aureus substrains (JKD6008, Newman, MRSA252, HO 5096 0412, N315), five 
Streptococcus pneumoniae substrains (670, ATCC_700669, G54, Hungary19A, 
Taiwan19F) and ten other common bacterial strains (Bacteroides fragilis 638R, 
Bifidobacterium bifidum BGN4, Clostridium perfringens ATCC 13124,  Enterococcus 
faecalis V583, Haemophilus influenzae 10810, Neisseria meningitidis MC58, 
Pseudomonas aeruginosa DK2, Staphylococcus epidermidis ATCC 12228, Streptococcus 
mitis B6, Streptococcus mutans UA159). The phylogenetic relationships between these 
strains and other strains available in the NCBI database are given in Figure 1, Figure 2 
and Figure 3 below. We used the Mason read simulator (Holtgrewe, 2010) to generate 
five sets of 100,000 reads for each strain simulating 100 bp single-end sequencing reads 
using an ‘Illumina-like’ sequencing error model; Mason parameters: ‘illumina -s ## -N 
100000 -sq -n 100 -i -hs 0.0 -hi 0 -hnN -nN’ (-s (Seeds) = 1101, 1102, 1103, 1104, 1105). 
We used PathoLib (-t 2 --subTax) to generate a reference library containing all bacteria. 
We used PathoMap (described below; default parameters) to index and align the reads to 
the bacterial library. PathoMap automatically splits the bacterial library into smaller parts 
(< 4.3GB in size) that the Bowtie2 aligner can handle process and combines the 
alignment filesthem together for the final alignment results. We then applied PathoID 
(versions 1.0 and 2.0) to the simulated datasets. PathoID version 1.0 uses the mapping 
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quality score in the alignment file and has no option to accept theta prior information, 
while PathoID version 2.0 uses the sequence alignment score and has options to accept 
theta prior information. PathoID version 2.0 was applied with default parameters and 
with two informative priors (low, high). The low informative prior corresponds to ‘-
thetaPrior 1000’ (equivalent to adding 1,000 non-unique reads to each genome) and high 
informative prior corresponds to ‘-thetaPrior 10**88’. The thetaPrior value here 
represents the number of non-unique reads that are not subject to reassignment. When we 
use a high thetaPrior value, it essentially removes the theta parameter and the non-unique 
indicator yi from the model. This is useful, when we know that there are multiple closely 
related strains possible in a sample, as in a disease caused by multiple strains of 
pathogens.  
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Figure 1: Selected 5 Escherichia coli substrains in the Taxonomy tree 
 
Five substrains of Escherichia coli were selected at random to cover all parts of the taxonomy tree. Previously downloaded from: http://www.ncbi.nlm.nih.gov/genome/?term=escherichia%20coli 
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Figure 2: Selected 5 Staphylococcus aureus substrains in the Taxonomy tree 
 
Five substrains of Staphylococcus aureus were selected at random to cover all parts of the taxonomy tree. Previously downloaded from:  http://www.ncbi.nlm.nih.gov/genome/?term=staphylococcus%20aureus 
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Figure 3: Selected 5 Streptococcus pneumoniae substrains in the Taxonomy tree 
 
   
Five substrains of Streptococcus pneumoniae were selected at random to cover all parts of the taxonomy tree. Previously downloaded from:  http://www.ncbi.nlm.nih.gov/genome/?term=streptococcus%20pneumoniae 
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Our simulated data consisted of five sets of 100,000 simulated Illumina reads 
derived from each of the 25 strains of bacteria. First, we processed the reads for each of 
the 25 bacterial strains individually using both PathoID version 1.0 and 2.0 with default 
parameter values and also PathoID 2.0 using a highly informative prior. Although 
PathoID 1.0 was able to estimate the correct proportions of reads at the species level 
(100% to the particular species) for each of these 25 samples, it was not able to estimate 
the correct proportions of reads at the strain level (100% to the particular strain) for six 
samples (Table 2). In contrast, PathoID 2.0 using default parameters estimated the correct 
proportions of reads at the strain level (100% to the particular strain) for all the 25 
samples. PathoID 2.0 with an informative prior estimated the correct proportions of reads 
at the strain level (100% to the particular strain) for 24 of the 25 samples, but was unable 
to estimate the correct proportion for one sample with S. aureus N315. The results are 
consistent for all five sets of simulated samples. The result for the first set of simulated 
samples is shown in Table 2. 
We also combined all the reads from the 25 strains, to create a dataset with all 
bacteria in equal proportions (expected proportion for each strain: 4%). Again, we 
applied both PathoID version 1.0 and 2.0 with default parameter values and added two 
informative theta priors (low and high as mentioned above). We saw marked 
improvement in PathoID version 2.0 over version 1.0, including increased accuracy with 
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informative priors (Table 2). For the 10 bacterial species that only included one strain per 
species, all methods performed well and estimated the correct read proportions. For the 
three species that contained multiple strains (E. coli, S. aureus, and S. pneumoniae), 
PathoID 1.0 and 2.0 at default parameters were able to identify all of the strains present, 
but struggled to estimate the correct read proportions. This failure demonstrates the 
tendency of the PathoID algorithm (at default parameters) to identify a single strain for 
each species, and if multiple strains or substrains are present it may reassign too many of 
the reads to a single strain. This tendency is an advantage in cases where there is only one 
strain of each species in the sample, but it leads to inaccuracies in the proportion 
estimates when multiple strains or substrains of the same species are present in the 
sample. The result of PathoID 2.0 with a highly informative prior matched closely with 
the expected proportions for 24 of the 25 strains, including 14 of the 15 cases with 
multiple strains of the same species. This demonstrates the value of using a highly 
informative prior when there are multiple strains of the same species in the sample, but 
we note that this comes at reduced effectiveness when there is only a single strain of each 
species in the sample.  
The one strain that was not estimated well using a highly informative prior was S. 
aureus N315, which had a final average read assignment percentage of 1.01%. After 
further evaluation, we observed that PathoID failed with this strain due to the ‘sequencing 
errors’ in our simulated reads that caused some of the N315 reads to align more closely to 
the related strains. This phenomenon limited the ability of PathoID to correctly estimate 
the correct read proportions for this strain. 
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Table 2: Single Strain Samples 
Bowtie2
Sample
Strain 
Level 
Rank
Strain Level 
Proportions
Thetaprior 
(High) 
Strain Level 
Proportions
Species 
Level 
Proportions
Strain 
Level 
Rank
Strain Level 
Proportions
Strain Level 
Proportions
Bacteroides fragilis  638R 1 99.94% 99.87% 99.97% 1 99.97% 55.62%
Bifidobacterium bifidum  BGN4 1 99.99% 99.99% 99.99% 1 99.99% 57.31%
Clostridium perfringens  ATCC_13124 1 99.90% 99.89% 99.91% 1 99.91% 72.58%
Enterococcus faecalis  V583 1 99.89% 99.89% 99.92% 1 99.92% 46.15%
Escherichia coli  042 1 99.82% 99.71% 99.87% 1 99.87% 31.49%
Escherichia coli  55989 1 99.71% 94.74% 99.75% 1 99.75% 8.84%
Escherichia coli SE11 1 99.67% 99.40% 99.73% 1 99.73% 12.41%
Escherichia coli  SE15 1 99.81% 99.63% 99.87% 1 99.87% 18.24%
Escherichia coli UMNK88 1 99.89% 99.78% 99.93% 1 99.93% 16.16%
Haemophilus influenzae 10810 1 99.79% 99.77% 99.85% 1 99.85% 49.68%
Neisseria meningitidis MC58 1 99.83% 97.78% 81.24% 2 18.72% 20.90%
Pseudomonas aeruginosa  DK2 1 99.92% 99.91% 99.95% 1 99.95% 30.31%
Staphylococcus epidermidis  ATCC_12228 1 99.71% 99.28% 99.81% 1 99.81% 48.70%
Streptococcus mitis  B6 1 99.73% 99.73% 99.75% 1 99.75% 90.32%
Streptococcus mutans  UA159 1 99.85% 99.73% 90.39% 2 9.59% 43.61%
Stapylococcus aureus HO_5096_0412 1 99.82% 99.75% 99.88% 1 99.88% 25.30%
Stapylococcus aureus  JKD6008 1 99.78% 95.53% 97.52% 2 2.35% 8.51%
Stapylococcus aureus  MRSA252 1 99.80% 99.10% 99.86% 1 99.86% 19.00%
Stapylococcus aureus  N315 1 99.83% 51.70% 95.23% 3 0.45% 6.02%
Stapylococcus aureus Newman 1 99.82% 96.96% 93.29% 2 6.61% 8.15%
Streptococcus pneumoniae 670-6B 1 99.77% 99.76% 99.85% 1 99.85% 17.95%
Streptococcus pneumoniae ATCC_700669 1 99.84% 99.81% 99.87% 1 99.87% 15.80%
Streptococcus pneumoniae  G54 1 99.69% 99.64% 99.76% 1 99.76% 15.01%
Streptococcus pneumoniae  Hungary19A-6 1 99.77% 99.75% 99.84% 1 99.84% 21.54%
Streptococcus pneumoniae Taiwan19F-14 1 99.79% 92.40% 99.30% 2 0.58% 11.10%
PathoID 2.0 PathoID 1.0
25 Samples with single strain of Bacteria (Expected proportion: 100%)  The simulated data consists of five sets of 100,000 simulated Illumina reads derived from each of the 25 strains of bacteria, which include five Escherichia coli substrains, five Staphylococcus aureus substrains, five Streptococcus pneumoniae substrains and ten other commonly occurring human bacterial strains. PathoID is our module for reassignment of reads based on the Bayesian Pseudo Likelihood mixture model. PathoID version 1.0 uses the mapping quality score in the alignment file and has no option to accept theta prior information, while PathoID version 2.0 uses the sequence alignment score and has options to accept theta prior information. We applied PathoID version 1.0 and 2.0 to the individual alignment file generated by PathoMap for each of the 25 bacterial strains separately. PathoID 1.0 identified correctly with the right proportions to the species level for all the strains of bacteria, but was not able to identify correctly to the strain level for few strains of bacteria. However, PathoID 2.0 correctly identified with the right proportions to the strain level for all of the 25 bacterial strains. The results are consistent for all the five sets of samples. Here, we present the first set of the samples. 
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  PathoID 1.0 PathoID 2.0 
Organism Default Default 
ThetaPrior 
(Low) 
ThetaPrior 
(High) 
Bacteroides fragilis 638R 4.00% 3.99% 3.99% 3.99% 
Bifidobacterium bifidum BGN4 4.00% 3.99% 3.99% 3.99% 
Clostridium perfringens ATCC_13124 3.99% 3.99% 3.99% 3.99% 
Enterococcus faecalis V583 3.98% 3.99% 3.99% 4.00% 
Escherichia coli 042 17.15% 4.01% 4.01% 4.02% 
Escherichia coli 55989 0.57% 0.50% 0.52% 3.83% 
Escherichia coli SE11 0.28% 10.10% 10.03% 3.74% 
Escherichia coli SE15 0.71% 3.43% 3.44% 3.82% 
Escherichia coli UMNK88 1.29% 1.95% 1.99% 4.16% 
Haemophilus influenzae 10810 3.98% 3.99% 3.99% 3.99% 
Neisseria meningitidis MC58 3.25% 3.99% 3.99% 3.92% 
Pseudomonas aeruginosa DK2 4.00% 3.99% 3.99% 3.99% 
Staphylococcus epidermidis ATCC_12228 3.97% 3.98% 3.98% 3.98% 
Streptococcus mitis B6 2.94% 3.82% 3.82% 3.94% 
Streptococcus mutans UA159 3.58% 3.99% 3.99% 3.99% 
Stapylococcus aureus HO_5096_0412 0.31% 1.76% 1.77% 3.80% 
Stapylococcus aureus JKD6008 0.05% 15.82% 15.75% 3.79% 
Stapylococcus aureus MRSA252 0.69% 1.46% 1.48% 3.85% 
Stapylococcus aureus N315 1 0.00% 0.68% 0.70% 1.01% 
Stapylococcus aureus Newman 0.15% 0.33% 0.34% 3.48% 
Streptococcus pneumoniae 670-6B 0.92% 3.28% 3.23% 4.43% 
Streptococcus pneumoniae ATCC_700669 0.29% 0.99% 1.02% 4.23% 
Streptococcus pneumoniae G54 0.16% 0.44% 0.47% 3.35% 
Streptococcus pneumoniae Hungary19A-6 19.42% 14.75% 14.70% 4.33% 
Streptococcus pneumoniae Taiwan19F-14 0.00% 0.66% 0.69% 2.83% 
1: Strain with maximum difference 
   
  
Table 3: Equal Proportion Simulation Study Results 
One Sample with 25 strains of Bacteria in equal proportions  
Shown here is the proportion of reads (Expected strain proportion: 4%)   The result of PathoID 2.0 with high theta priors matched closely with the expected proportion of 4%, except for one bacterial strain in particular - S. aureus N315, where the proportion was less by about 3%. The low informative prior corresponds to ‘-thetaPrior 1000’ and high informative prior corresponds to ‘-thetaPrior 10**88’. 
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Sensitivity Analysis with unequal proportions 
We performed a simulation with unequal proportions of reads with the 25 strains 
of bacteria from the study mentioned above to perform sensitivity analysis of PathoID 
when there are closely related strains in different proportions. We noticed as shown in 
Table 4 below that PathoID 2.0 performed very well. The results were consistent with the 
mixtures at equal proportions, that is, the strains for which the proportions were not 
accurate with the mixtures at equal proportions matched with that of the mixtures at 
random proportions.  
The maximum average difference between the true proportion and the proportion 
predicted by PathoID is 2.5% and the total difference is only 6.48%. Even in the extreme 
case where multiple closely related strains are present and in combination with read 
sequencing errors, the total difference is less than 8%. This shows the capability of 
PathoID to distinguish even closely related strains in the samples and also the ability to 
estimate accurately the proportions of pathogens found in the samples. Hence, we can 
conclude that if the reads are of good quality, the proportion estimates of pathogens by 
PathoID is very reliable. 
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Sample Id Sample 1 Sample 2 
Organism Actual PathoID2 |Diff| Actual PathoID2 |Diff| 
Bacteroides fragilis 638R 7.41% 7.40% 0.01% 4.00% 3.99% 0.01% 
Bifidobacterium bifidum BGN4 3.70% 3.70% 0.01% 8.00% 8.00% 0.00% 
Clostridium perfringens ATCC_13124 11.11% 11.09% 0.02% 0.00% 0.00% 0.00% 
Enterococcus faecalis V583 7.41% 7.42% 0.01% 0.00% 0.00% 0.00% 
Escherichia coli 042 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Escherichia coli 55989 3.70% 3.58% 0.12% 4.00% 3.92% 0.08% 
Escherichia coli SE11 7.41% 7.08% 0.32% 4.00% 3.77% 0.23% 
Escherichia coli SE15 3.70% 3.48% 0.23% 8.00% 7.97% 0.03% 
Escherichia coli UMNK88 7.41% 7.76% 0.36% 0.00% 0.00% 0.00% 
Haemophilus influenzae 10810 3.70% 3.68% 0.02% 12.00% 11.97% 0.03% 
Neisseria meningitidis MC58 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Pseudomonas aeruginosa DK2 3.70% 3.68% 0.02% 4.00% 3.99% 0.01% 
Staphylococcus epidermidis ATCC_12228 3.70% 3.70% 0.01% 4.00% 3.97% 0.03% 
Streptococcus mitis B6 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Streptococcus mutans UA159 3.70% 3.70% 0.00% 8.00% 7.97% 0.03% 
Stapylococcus aureus HO_5096_0412 0.00% 0.00% 0.00% 8.00% 7.97% 0.03% 
Stapylococcus aureus JKD6008 3.70% 3.34% 0.37% 4.00% 3.65% 0.35% 
Stapylococcus aureus MRSA252 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Stapylococcus aureus N315 1 3.70% 1.03% 2.67% 4.00% 0.99% 3.01% 
Stapylococcus aureus Newman 3.70% 3.37% 0.33% 4.00% 3.47% 0.53% 
Streptococcus pneumoniae 670-6B 7.41% 8.21% 0.80% 4.00% 4.07% 0.07% 
Streptococcus pneumoniae ATCC_700669 3.70% 3.84% 0.13% 12.00% 12.70% 0.70% 
Streptococcus pneumoniae G54 3.70% 3.02% 0.69% 4.00% 3.12% 0.88% 
Streptococcus pneumoniae Hungary19A-6 3.70% 3.89% 0.18% 4.00% 4.08% 0.08% 
Streptococcus pneumoniae Taiwan19F-14 3.70% 2.49% 1.22% 0.00% 0.00% 0.00% 
Max Difference   2.67% 2.67%   3.01% 3.01% 
Total Difference   7.52% 7.52%   6.09% 6.09% 
1: Strain with maximum difference 
    
 
Table 4: Unequal proportion Simulation Study Results 
Result of PathoID 2.0 with high prior value on unequal proportions mix of 25 
strains of bacteria We ran a simulation with the 25 strains of bacteria mixed in unequal proportions and created ten different samples, which we analyzed using PathoID 2.0 with very high theta priors. Shown here are two samples and the results are consistent across the ten samples. The maximum average difference between the true proportion and the proportion predicted by PathoID 2.0 is 2.5% and the total difference is only 6.48%. Even in the extreme case where multiple closely related strains are present, the total difference is less than 8%. 
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Aim 1B 
Evaluate how many sequencing reads are needed (read coverage) to estimate 
pathogens proportions within a given confidence limit, and determine how long it takes to 
estimate microbial proportions within a given confidence limits using our mixture model 
and in comparison to other methods. 
 
Objective 
Develop statistical methods for deriving confidence intervals for metagenomic 
sequencing data. Establish the minimum number of reads required to estimate microbial 
proportions to a given confidence level. Establish the time and read coverage required for 
estimating the pathogen proportions to these limits. 
 
Rationale 
It costs time and money to perform sequencing and analysis. Hence, it is 
important to estimate the pathogen proportions accurately within the given confidence 
limit using minimal number of reads to save on cost and time. Our methods and this 
simulation study will give insights into the number of reads and time required under 
different scenarios.  
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Experimental Plan 
To find the effect of the number of reads on accuracy, a simulation of samples 
with varying number of reads will be performed. As an example, we will use 92,370 
sequencing reads from E.coli O104:H4 pathogen (SRR227300). A simulation of 1000 
samples with randomly picked sets of 9,237 reads (0.13X read coverage), 924 reads 
(0.01X read coverage), and 92 reads (0.001X read coverage) will be performed to 
compare the true proportions with the estimated proportions using our Bayesian mixture 
model approach. 
 
Comparison of Metagenomics Analysis methods 
The key to identifying and estimating the correct proportions of pathogens present 
in a sample is to perform the task of reassignment of reads to the correct genome after 
alignment of reads by aligners such as Bowtie and BLAST. The Bayesian Pseudo 
Likelihood mixture model with EM (Expectation Maximization) parameter estimation 
mentioned above (PathoID 2.0) for reassignment is a powerful approach that is expected 
to be both accurate and fast. The performance of EM approach is compared with other 
methods such as naïve alignment, ReadScan (Naeem, Rashid & Pain, 2013), RINS 
(Bhaduri et al., 2012), PhymmBL (Brady & Salzberg, 2009), MetaPhlAn (Segata et al., 
2012) and MEGAN (Huson et al., 2007). We also applied an alignment approach using 
the Trinity assembler (Grabherr, Haas, Yassour et al., 2011) to assemble high-quality 
contiguous sequences (contigs) from the reads, followed by the probabilistic alignment of 
the contigs to the database. 
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Real data samples 
For the comparison of our Bayesian mixture model with other methods, real data 
samples are selected from fecal specimens obtained from patients with diarrhea during 
the 2011 European outbreak of Shiga-toxigenic Escherichia coli (STEC) O104:H4 
(NCBI accession: ERP001956) (Rohde, Qin, Cui et al., 2011; Turner, 2011). 
Misidentification was among the issues that resulted in a 3-wk delay in accurate 
diagnosis of this outbreak, resulting in over 3800 infections across 13 countries in Europe 
with 54 deaths (Frank, Werber, Cramer et al., 2011).    
Analysis 
For this example, we used the full dataset of 92,370 reads, representing 1.3X coverage of 
the reference O104:H4 genome, as well as reduced datasets using 1,000 random 
subsamples reads for each of the following sample sizes: 9,237 (0.13X), 924 (0.01X), and 
92 (0.001X). For the smaller subsets (92, 924, 9,237), we compared the average accuracy 
and range across samples for each method. These smaller sets were designed to evaluate 
algorithmic performance when the reads are generated using multiplexed sequencing runs 
or when they originate from contaminated samples that may be dominated by other 
genomic sources. However, we note that for MEGAN (graphical user interface),  and 
PhyloPhythiaS (manual webserver), and the assembly approach, we did not use 1,000 
random datasets; rather we used a single random sample of each data set size, as they 
would either require thousands of manual submissions or an excessive amount of 
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computation time. Table 5 contains the average accuracy and range across samples for 
each algorithm.  
 
Naïve alignment, PhymmBL, and MetaPhlAn:  
The naïve algorithm consistently assigned around 16% of the read probability to 
the O104:H4 strain independent of the number of reads used. However, on average 
between 7.4% and 9.4% of the read probability was assigned to the 55989 strain of E. 
coli, which is the closest fully sequenced genome to the O104:H4 strain (Rohde et al., 
2011; Turner, 2011). Several other E. coli strains received 1-3% of the reads, and several 
species in the Shigella genus also received 1-2% of the reads. In all, roughly 93% of the 
read probabilities were assigned to an E. coli strain. The PhymmBL algorithm assigned 
14.7% on average to O104:H4 strain and exhibited similar profiles of false mapping to 
other strains and species. Overall the performance of PhymmBL was only slightly better 
than the naïve approach. The MetaPhlAn algorithm aligns reads to taxonomic clade-
specific markers, which in its current implementation can only identify DNA templates at 
the species level—and therefore cannot distinguish between strains or substrains of the 
same species. In addition, because it only uses short clade markers are used, merely 815 
(0.9%) of the reads were assigned by MetaPhlAn. Of these reads only 90.0% were 
aligned to E. coli, whereas 9.6% were incorrectly assigned to S. dysenteriae. The method 
gave inconsistent results for the subsamples of 9,237 and most of the time failed to assign 
any reads to E. coli for the subsamples of 92 and 924. From these approaches, it is clear 
that an E. coli strain is present in the sample and the naïve and PhymmBL approaches 
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point to O104:H4 as the most likely source, but all results are ambiguous as to whether 
there are multiple E. coli strains or other species present in the sample.  
 
Genome assembly approach:  
For the assembly approach, no contigs were generated from the 92 and 924 read 
data sets. For the data set with 9237 reads, only five contigs were generated, ranging in 
length from 221 bases to 442 bases in length. Although these five contigs best matched to 
the O104:H4 strain, they also aligned to several other (incorrect) genomes in the 
database. Finally, on the complete sequencing run representing 1.3X coverage of the 
genome, the assembler constructed 3637 short contigs with only 21.5% of the contig 
mapping probability being assigned to the correct strain. Therefore, although this 
approach is a slight improvement over the naïve approach, it is clear that a single 
sequencing run for a purified (single source) sample is not sufficient for strain attribution 
using an assembly-based approach.  
 
PathoID reassignment:  
In contrast, PathoID reassigned, on average, 99.4% of the read probability directly 
to the O104:H4 strain for the data sets with 92 reads and averaged 99.6% of the reads 
correctly for the larger data sets. These results imply that PathoID is a substantial 
improvement over naïve mapping, context mapping, and assembly-based methods for 
species identification and strain attribution. 
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Identification of the nearest genome:  
The results from the MEGAN and PhyloPythiaS analyses were not included in the 
previous section because the annotation tables used by these approaches do not contain 
the O104:H4 strain (and cannot be manually added by the user). For this reason, we 
removed the O104:H4 strain from our reference database and reanalyzed the query reads 
using the naïve mapping and PathoID reassignment. In addition, we note that the 
PhyloPythiaS web server only allowed for a maximum of 10,000 reads for each 
submission, so the results presented here were based on random sets of 92, 924, and 9237 
only (and not the full data set).  
For the naïve mapping with O104:H4 removed, most of the aligned reads (99.8%) 
mapped to at least one strain of E. coli, thus rapidly and clearly identifying the species of 
origin. However, 96.1% of these reads aligned ambiguously to multiple E. coli strains. 
The 55989 strain received the largest proportion of the aligned reads (9.5%), followed by 
the O103:H2 strain (3.2%), the B7A, O26:H11, E24377A, and the E22 strains (3.1%), 
then the SE11 and IAI1 strains (3.0%). Therefore, although the correct species was easily 
identified using a naïve mapping strategy, the identification of the correct strain within 
the species proves to be more difficult, and a simple mapping strategy leaves much 
uncertainty in the process of identifying the strain most similar to the origin strain. This 
uncertainty can prove to be important for E. coli—which contains both benign and 
harmful strains—as the misclassification of the origin or nearest strain might lead to 
negative economic and human health consequences. 
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In contrast, the lowest common ancestor approach utilized by MEGAN assigned 
80.2% of the reads to the family taxonomic level or higher. The remaining reads were 
assigned at the genus level; 19.7% of the total reads were assigned to the Escherichia 
genus and 0.2% of the reads were incorrectly assigned to the Shigella genus. MEGAN 
did not assign any reads at the species or strain level for any of the data sets. 
PhyloPhythiaS also performed poorly on this example: Overall, >84% of the reads were 
assigned to the family level or above, and <50% of all the reads were correctly assigned 
E. coli taxonomy levels. Furthermore, 32 incorrect genera received more reads than 
Escherichia, and five incorrect species received more reads than E. coli. 
After application of the PathoID reassignment, 89.5% of the reads were 
reassigned to the 55989 strain. The genomes with the next highest read proportions were 
the O157:H7 strain (3.2%) and the O103:H2 strain (1.1%). Therefore, even though our 
approach did not completely converge on one genome (as it should not, because 
in this analysis the origin strain was not present in the database), it is clear that PathoID 
can clearly and definitively identify the closest fully sequenced neighboring strain with 
high confidence. 
To evaluate whether the lack of sensitivity for MEGAN and PhyloPythiaS is due 
to the missing O104:H4 annotation, we applied MEGAN and PhyloPhythiaS to our 
analysis of reads from the E. coli K-12 MG1655 substrain, which is contained in the 
annotation. For MEGAN, the result was similar, in that all of the reads were assigned at 
the genus level or higher. For PhyloPythiaS, 98.5% of the reads were assigned to the 
genus level or above, and 34.7% of the reads were assigned to incorrect taxonomies. 
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The E. coli species only received 1.4% of the reads, and no reads were assigned at the 
strain or substrain level. Therefore, these methods can fail to identify substrains, even 
when they are present in the annotation. 
 
Computational Time:  
MetaPhlAn was by far the fastest algorithm (Table 5), requiring only 1 minute to 
complete because it aligns the reads to a set of small clade markers, however, the 
approach assigned less than 1% of the reads in this example. The naïve approach required 
38 minutes for a BLAST alignment and 13 minutes for Bowtie2. PathoID and MEGAN 
used the naïve alignments and required an additional 7 minutes and 3 minutes, 
respectively. PylopythiaS required a total of 7 minutes to assign 9,237 reads. PhymmBL 
required ~36hrs of database preprocessing, and then approximately 2 hours to assign the 
reads. Finally, the assembly approach required 30 min to complete. 
 
Conclusion 
It is clear that PathoID is the most effective algorithm for strain identification. 
Based on this experiment, we recommend that for single strain identification, about 0.1X 
coverage of reads is sufficient to get more than 99% accuracy using PathoID.    
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 % of Reads to Correct Genome (Second Highest) [Range for 1,000 Random Samples] 
Time Required  
(Full Dataset) 
Number of 
Reads 
(Coverage) 
92 
(0.001X) 
924 
(0.01X) 
9,237 
(0.13X) 
92,370 
(1.3X)  Naïve mapping 12.9 (6.5) [7.5-20.9] 12.9 (6.1) [10.5-15.5] 12.9 (7.4) [12.2-13.5] 12.9 (7.4) BLAST: 38min Bowtie2: 13min PathoID 99.4 (0.5)  [95.1-100.0] 99.6 (0.3)  [98.0-100.0] 99.6 (0.3)  [99.3-99.8] 99.6 (0.3)   Naïve + 7min PhymmBL 14.7 (7.0)  [4.3-26.1] 14.7 (7.0)  [11.3-18.5] 14.7 (7.1)  [13.6-15.7] 14.7 (7.1)   13hrs** MetaPhlAn (species only) -- 36.1 (0.0) [0.0-100.0] 96.9 (2.4) [54.1-100.0] 90.0 (9.6) 1 min Trinity Contigs -- -- 70.8 (22.6) 21.5 (13.4) 30 min PhylopythiaS*      7 min**   Family (or above) 47.8 (7.6) 48.4 (2.2) 45.6 (2.8) --    Genus 0.0 (2.2) 0.1 (1.6) 0.1 (1.2) --    Species 0.0 (0.1) 0.0 (0.2) 0.1 (0.3) --  MEGAN*      Naïve + 3min   Family (or above) 84.7 (0.0) 79.5 (0.0) 80.2 (0.0) 80.2 (0.0)    Genus 16.3 (0.0) 20.5 (0.0) 19.6 (0.2) 19.7 (0.2)    Species/Strain* -- -- -- --  
 
Table 5: PathoScope comparison on O104:H4 dataset 
   
Shown here are the results from the application of several species identification approaches to subsets of the 92,370 sequencing reads from the first O104:H4 Ion Torrent sequencing run (Guilford, CT) (SRR227300) (Li, Xi, Zhao et al., 2011). It shows the percentages of all reads assigned to the correct genome along with the second highest scoring genome in parenthesis. It is clear that PathoID is the most effective algorithm for strain identification. Based on this experiment, we recommend that for single strain identification, about 0.1X coverage of reads is sufficient to get more than 99% accuracy using PathoID. For MEGAN and PhyloPythiaS, the O104:H4 annotation is not available, so the nearest strain E. coli 55989 was considered the ‘correct’ strain.  *Source strain was not contained in annotation ** PhymmBL also required 36 hours of database preprocessing, and PhyloPhythiaS was only applied to 9,237 reads and not the whole dataset. 
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Aim 1C 
Develop a complete software pipeline for metagenomics analysis of next-
generation sequencing data in collaboration with others with leading and major 
contribution to the design and development of the pipeline 
 
Objective 
Develop a complete and flexible ‘plug-n-play’ software pipeline, called 
PathoScope, for the metagenomic analysis of samples, including library preparation, 
alignment of reads, and reassignment of reads to the correct source genome, and 
preparing a complete report with the proportion of each the genomes that are present in 
the sample. 
 
Rationale 
There are several software packages that are currently available for performing 
specific parts of these types of metagenomic analysis. However, none of them provides a 
complete solution to perform the complete analysis that includes library preparation, 
target alignment and filtration, and reassignment to the correct source genome. The 
software pipeline developed in this project is efficient, utilizing a powerful the Bayesian 
framework, and provides a complete metagenomics analysis toolkit. 
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Experimental Plan 
Develop PathoScope, a complete software pipeline comprising of four core 
modules and with the option to add addition optional modules into a software toolkit for 
metagenomics analysis of sequencing samples. The four core PathoScope modules are 
the following 1) PathoLib: automatic reference library curation and preparation; 2) 
PathoMap: alignment of reads to target reference libraries and filtration of host or 
commensal species; 3) PathoID: accurate identification of species present in the sample 
and quantification of the relative abundances of each species; and 4) PathoReport: 
detailed, annotated results in a user-friendly report and output format. These approaches 
are described in detail below.  
 
Methods 
We have developed a complete software pipeline with different plugin modules 
for easy extensibility and maintainability. Along with the four core modules namely 
PathoLib, PathoMap, PathoID and PathoReport, there are two optional modules namely 
PathoDB (Database to store detailed information about the reference sequences) and 
PathoQC (Quality control of input read sequences) that can be plugged in to add more 
functionality to this pipeline. 
PathoScope 2.0 provides a complete modular bioinformatics workflow to analyze 
metagenomic sequence data from clinical or environmental samples as shown in Figure 4 
below.  
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Figure 4: PathoScope workflow 
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PathoID
Patho
Report
Core Components
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Automatic genome library extraction
PathoMap:
Alignment and Filtering of reads
PathoID:
Identify strains or substrains and estimate 
proportions
PathoReport:
Detailed XML report
Identify
Report
Profile
PathoScope
Samples Sequencing
The PathoScope workflow start with collection of samples from patients or soil or some environmental conditions for metagenomics analysis. The sample is processed through a sequencing platform for DNA/RNA sequencing of data and typically a fastq/fasta file is obtained as an output from the sequencing machine. The data read file (fasta/fastq) is analyzed for quality of reads using PathoQC (optional module). PathoLib is used for building reference library such as virus/bacteria. The reads are mapped to the target reference genomes and filtering of read mappings to filter reference genomes (e.g. host genomes) using PathoMap. The alignment file from PathoMap is reassigned to the correct genomes of origin using PathoID and reports are generated using PathoReport with information from PathoDB. 
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PathoLib: Automatic reference library extraction 
PathoLib is a module for generating custom reference genome libraries. The 
careful selection of a refined reference sequence library is crucial for all downstream 
analyses. The PathoLib module allows the user to automatically generate custom 
reference genome libraries for specific scenarios or datasets. The user supplies a set of 
NCBI taxonomy identification (taxID) numbers for organisms to be included in the 
library (Figure 5). The user can construct both a ‘target library’ (that is, pathogen 
genomes of interest) and a ‘filter library’ (for example, host genome or benign flora) for 
later use in the PathoMap module. The PathoLib module will extract all sequences in the 
NCBI nucleotide database associated with the taxIDs (for example, complete genomes, 
transcripts, plasmids, partially assembled fragments, and so on). In addition, if a high-
level taxID is given (for example, kingdom, family, genus), PathoLib can also optionally 
extract all lower level sequences in the NCBI taxonomy tree. As PathoLib extracts the 
reference library, the NCBI GeneInfo number is linked to the taxID, and the taxID and 
organism name are appended to the sequence headers to further link sequences in 
downstream analyses. 
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Figure 5 PathoLib module workflow 
The PathoLib module will extract a reference library containing all genomes, chromosomes, transcripts, and other sequence fragments in the NCBI redundant nucleotide database associated user-defined taxonomic clade (NCBI taxID). If a higher-level taxID is given, PathoLib will optionally extract all sequences from lower-lever taxonomic designations based on the NCBI taxonomy tree. 
  
50 
 
PathoMap: Efficient read alignment and filtering 
PathoMap is a module for aligning reads to the target reference library and filter 
out any reads that aligns better to filter reference library (Figure 6). Inputs for this module 
are the raw read file (FASTQ) and both the target and filter reference libraries (FASTA 
format). PathoMap will: (1) index the reference library (splitting the library into multiple 
indices if necessary); (2) align the reads to the target library; and (3) filter any of the 
target-matching reads that also match the filter library. The current version of PathoMap 
includes a Bowtie 2 (Langmead & Salzberg, 2012) wrapper (see Figure 6) with 
predetermined optimal alignment parameters for different read generation technologies 
(for example, Illumina: ‘–very-sensitive -k 100 –score-min L,-0.6,-0.6’; PacBio: ‘–very-
sensitive -k 100 –score-min L, -0.6, -1.5’). The module also allows flexibility for the user 
to manually input Bowtie 2 parameters, or to conduct any part of the alignments outside 
the PathoMap framework by supplying an alignment file in SAM format (Li, Handsaker, 
Wysoker et al., 2009). Finally, the module is constructed in a way that wrappers for 
additional alignment algorithms can easily be substituted for the Bowtie 2 wrapper to 
accommodate diverse user preferences. 
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Figure 6 PathoMap module workflow  
The PathoMap module aligns reads to the target library and removes any sequences that align to the filter library. PathoMap will: (1) index the reference library; (2) align the reads to the target library; and (3) filter any of the target-matching reads that also match the filter library. The current version of PathoMap includes a Bowtie 2 wrapper and allows users to conduct any part of the alignments outside the PathoMap framework. 
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PathoID 
PathoID is a module for reassigning all ambiguous reads to the most likely source 
genome in the reference library based on the Bayesian Pseudo Likelihood mixture model. 
This model is described in detail in Aim 1A. This module will take either a SAM or 
BLAST alignment file as input and outputs a TSV (Tab Separated Value) with the 
genomes ranked according to the final guess of the proportions estimated after running an 
EM (Expectation Maximization) to maximize the likelihood calculated based on the 
Bayesian Pseudo Likelihood mixture model. The mixture model will include the 
alignment scores, reference genome length and user-defined priors for read proportions 
and ambiguity penalties and weights the likelihood accordingly to increase the number of 
reads that are correctly assigned to the source genome. This module will also optionally 
generate an updated SAM file with the updated alignment MapQ scores based on the 
final reassignment score this module computes for each read alignment. 
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Figure 7 PathoID module workflow 
 
This module will take either a SAM or BLAST alignment file as input and outputs a TSV (Tab Separated Value) with the genomes ranked according to the final guess of the proportions estimated after running an EM (Expectation Maximization) to maximize the likelihood calculated based on the Bayesian Pseudo Likelihood mixture model. The mixture model will include the alignment scores, reference genome length and user-defined priors for read proportions and ambiguity penalties and weights the likelihood accordingly to increase the number of reads that are correctly assigned to the source genome. This module will also optionally generate an updated SAM file with the updated alignment MapQ scores based on the final reassignment score this module computes for each read alignment. 
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PathoReport 
PathoReport is a module for detailed result reporting and annotation. The 
PathoReport module (Figure 8) outputs two files from the pipeline. The first output file is 
a tab-delimited (.tsv) report that contains the genomes that were identified by the 
previous steps sorted by rank, along with high/low confidence read numbers and 
proportions assigned to each genome. The second file, in XML format, contains more 
detailed results, including the reads assigned to each genome and contiguous sequences 
(contigs) constructed from overlapping reads. In addition, in concert with the plug-in 
module PathoDB (described below), PathoReport will add additional annotation into the 
report such as organism lineage, gene loci, and protein products for genes covered by the 
reads. This XML output provides useful information for evaluating the quality of the 
results and facilitating downstream interpretation and analysis. For example, the specific 
reads assigned to a genome can be an important quality check for a metagenomic analysis 
to check if the reads are low complexity or contain multiple PCR duplicates. The contigs 
show the breadth of genomic coverage, can identify sequence variation from the 
reference, and facilitate scaffold-based genome assembly. The gene annotations identify 
the specific genes covered by the reads, can be used to annotate SNPs in specific genes, 
and (in RNA-seq studies) can identify which pathogenic genes are actively expressed. 
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Figure 8 PathoReport module workflow 
 
The PathoReport module outputs two report files including: (1) a tab-delimited (.tsv) report that contains a ranked list of genomes (with proportions) identified by the pipeline; and (2) an XML file containing detailed results including the reads assigned to each genome, contigs constructed from overlapping reads, and so on. 
  
56 
PathoDB (optional module) 
PathoDB is an optional database module that contains taxonomy, gene, and 
protein product annotation for all sequences in the NCBI nucleotide database (Figure 9). 
The information in the PathoDB is used to generate detailed XML reports for further 
analysis.  
 
Figure 9 PathoDB module workflow 
PathoDB is an optional module of pre-compiled annotation for all sequences in the NCBI nucleotide database. The PathoDB module automatically interacts with PathoReport to provide additional annotation in the detailed (XML) report such as organism lineage, gene loci, and protein products for any genes covered by the reads. 
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PathoQC (optional module) 
PathoQC is an optional module for quality control of input read sequences. It 
performs several read quality control steps including trimming adapters, trimming low 
quality bases, and filtering low complexity reads (Figure 10). I helped with integrating 
PathoQC into the PathoScope framework and is described in detail in the Cancer 
Informatics publication (Hong, Manimaran & Johnson, 2014a). 
 
Figure 10 PathoQC module workflow 
PathoQC is an optional module for quality control of input read sequences. Shown are the steps performed by PathoQC. 
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The complete design of the PathoScope 2.0 framework is presented in the 
Appendix. The pipeline helps researchers to efficiently generate custom reference 
libraries, align reads to a target library, filter host reads, overcome read alignment 
ambiguity, characterize target diversity, and annotate results. Our simulated and real-data 
examples show that PathoScope 2.0 is a highly sensitive and efficient approach for 
metagenomic analysis, without the need for computationally intensive database 
preprocessing and time-consuming de novo assembly. PathoScope 2.0 is a fast and 
modularized pipeline for which we provide a comprehensive command line interaction so 
that more advanced users can selectively run parts of the modules, but is user-friendly 
enough to be used by researchers without strong computational backgrounds. I have led 
the design and development of the PathoScope 2.0 pipeline, which is described in detail 
in the Microbiome journal publication (Hong et al., 2014b). PathoScope 2.0 is available 
as a python module for download from the sourceforge at 
https://sourceforge.net/projects/pathoscope/.  I have contributed to the development of a 
clinical version of PathoScope called clinical PathoScope, which is described in detail in 
the BMC Bioinformatics publication (Byrd, Perez-Rogers, Manimaran et al., 2014) and is 
available for download from the same sourceforge URL given above. 
PipelineBuild  
 I have developed a python program called PipelineBuild to build custom pipeline 
for analysis using PathoScope modules. Using PipelineBuild, the user specifies a 
template of commands to run for each sample. An example template file is given below, 
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where the user wants to run PathoMap and PathoID and clean intermediate files. With 
PipelineBuild, it will automatically generate all the commands for all the samples found 
in a directory based on the template for one sample. This is very useful when a user wants 
to analyze many samples using the PathoScope pipeline. 
Example Template: 
pathoscope/pathoscope.py MAP -1 @@FILE1@@ -2 @@FILE2@@ -
targetIndexPrefixes bacteria_ti_0,bacteria_ti_1 -filterIndexPrefixes 
human1_bowtie2,human2_bowtie2 -indexDir indexdir -outDir outdir -outAlign 
@@FILE1MATCH@@.sam -expTag @@FILE1MATCH@@ -targetAlignParams "--
very-sensitive-local -k 10 --score-min L,20,1.0" 
rm -f outdir/@@FILE1MATCH@@-*.* 
pathoscope.py --verbose ID --noUpdatedAlignFile --noDisplayCutoff -alignFile 
outdir/@@FILE1MATCH@@.sam -outDir outdir -expTag @@FILE1MATCH@@ 
 
The PipelineBuild program is available at the following URL: 
https://github.com/mani2012/PipelineBuild.  
 
SplitQsub  
I have also developed a python program called SplitQsub for creating scripts for 
parallel execution in a server cluster environment. Using SplitQsub  the user specifies a 
template for the generation of a qsub file 
(http://www.bu.edu/tech/support/research/system-usage/running-jobs/submitting-jobs/) 
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to be submitted to a server cluster for execution. An example qsub header file is given 
below. Using SplitQsub, users can generate qsub files for a set of commands, usually 
generated in combination with the PipelineBuild program mentioned above. Once these 
qsub files are generated, they can be submitted to the server cluster for execution. Usually 
multiple qsub files are submitted together for execution of multiple commands in parallel 
in a server cluster environment. 
 
Example Template: 
 #!/bin/bash -l 
 # 
 #$ -cwd 
 #$ -N @@QNAME@@ 
 #$ -o @@QNAME@@Log 
 #$ -j y 
 #$ -m be 
 #$ -M <put your email address here> 
 #$ -P pathoscope 
 #$ -pe single_node 8-8 
 ### -l h=scc-cb4 
 ### -l h_rt=24:00:00 
  echo "==========================================================" 
 echo "Starting on       : $(date)" 
 echo "Running on node   : $(hostname)" 
 echo "Current job ID    : $JOB_ID" 
 echo "Current job name  : $JOB_NAME" 
 echo "Task index number : $TASK_ID" 
 echo "==========================================================" 
  module load python/2.7.5  
 
The SplitQsub program is available at the following URL:  
https://github.com/mani2012/SplitQsub. 
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Conclusion 
We developed a statistical framework for metagenomic analysis of next-
generation sequencing data using a Bayesian mixture model with a modified pseudo 
likelihood model. Based on this model, we developed a complete software pipeline called 
PathoScope to identify microbes and pathogens to the strain level. We performed 
simulation studies to determine how accurately microbial proportions can be estimated 
when there is a mixture of multiple microbes with varying proportions in the sample. We 
evaluated the accuracy of the Bayesian mixture modeling approach in comparison to 
other methods and also evaluated how prior information in the Bayesian mixture 
modeling improves these estimates. We performed a simulation study to evaluate the read 
coverage needed to estimate pathogen proportions to a given confidence limit. Based on 
this study, we recommend that for single strain identification, about 0.1X coverage of 
reads is sufficient to get more than 99% accuracy using PathoScope. PathoScope 2.0 is 
available as a python module for download from the sourceforge at 
https://sourceforge.net/projects/pathoscope/. 
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CHAPTER THREE 
Project 2: A Toolkit for Microbiome Variation Analysis 
Introduction 
 The microbiome can vary significantly between different biological conditions 
such as disease status or treatment differences or other covariates of interest within an 
organism or environment. Studying the variation of microbiomes under different 
conditions within an organism or environment is the key to diagnosing diseases and 
providing personalized treatments. For this project, the goals are the following: A) 
Identify various statistical measures such as alpha and beta diversity for characterizing 
the microbiome variation under different conditions and develop a module for 
visualization of the statistical measures; B) Develop a module to calculate and display the 
confidence regions for the relative abundance estimates; C) Perform Multi-dimensional 
and differential expression analysis of microbiomes under various conditions of interest; 
D) Develop a software pipeline called PathoStat for Microbiome variation analysis. 
 
Aim 2A 
Summarize various statistical measures such as alpha and beta diversity for 
characterizing the microbiome variation under different conditions and develop a pipeline 
module, PathoStat, for visualization of the statistical measures. 
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Objective 
Develop a software pipeline to visualize the difference between samples in terms 
of various statistical diversity measures, particularly when samples contain microbes of 
varying proportions. 
Rationale 
When samples contain microbes of varying proportions, it is difficult to 
characterize the microbial variations between samples. The first step in this analysis is to 
visualize the variations and compare the statistical diversity measures to numerically 
characterize the variations. 
Experimental Plan 
Identify multiple statistical measures such as alpha and beta diversity and develop 
a software pipeline module, PathoStat, to visually display the microbiome variations in 
the multidimensional space by projecting along user selected dimensions and including 
the statistical diversity measures for comparison between samples.  
Taxonomy Levels 
When analyzing microbiome variations, it is useful to group together similar 
organisms and study its relative abundance and the variations of it as a group with 
different biological conditions. Biologically, organisms are grouped based on shared 
characteristics in a taxonomic hierarchy (Nomenclature., Ride, Nomenclature. et al., 
1999). The taxonomic ranks that we have used are species, genus, family, order, class, 
phylum and kingdom.  
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For example, let us consider a particular species, the red fox Vulpes vulpes. Its 
genus is Vulpes, which comprises of all the 'true foxes'. The next higher rank is the family 
Canidae, which includes their closest relatives, dogs, wolves, jackals, all foxes, and other 
caniforms such as bears, badgers and seals; the next level, the order Carnivora, includes 
feliforms and caniforms (lions, tigers, hyenas, wolverines, etc.), plus other carnivorous 
mammals. This order is one group of the class Mammalia, all animals with backbones are 
classified in the Chordata phylum rank, which can be found among all other animals in 
the Animalia kingdom rank (Nomenclature. et al., 1999). 
 
Diversity Measures 
The terms ‘alpha’, ‘beta’ and ‘gamma’ diversity were introduced originally by R. 
H. Whittaker (Whittaker, 1972). Alpha diversity refers to diversity within a local site or 
as a diversity measure of microbiome within a sample or samples from the same 
covariate conditions of interest. Beta diversity refers to diversity across multiple sites or 
the diversity measure across multiple samples from different covariate conditions. 
Gamma diversity corresponds to the total diversity within and across multiple sites and in 
our case refers to the total diversity both within and across samples of different covariate 
conditions. Furthermore, researchers have commonly used principal components analysis 
(PCA) (Yeung & Ruzzo, 2001) or principal coordinates analysis (PCoA) to analyze and 
visualize microbiome data. Our software pipeline called PathoStat integrates all these 
types of measures and exploratory analyses for microbiome variation analysis in one 
place. There is another software called QIIME (Navas-Molina, Peralta-Sanchez, 
  
65 
Gonzalez et al., 2013; Kuczynski, Stombaugh, Walters et al., 2012) that does some of 
these analysis for 16SrDNA (Woo, Lau, Teng et al.) data, but our software PathoStat can 
perform the analysis on 16SrDNA data as well as on metagenomic (Thomas, Gilbert & 
Meyer, 2012) data and it has more functionalities such as different types of multi-
dimensional analysis. 
 
Alpha diversity 
PathoStat has a module to display the alpha diversity based on Shannon’s diversity index, 
Simpson index and Inverse Simpson index. These measures are discussed in the 
following paragraphs below. 
Shannon’s diversity Index: 
Shannon’s diversity index is popular in the ecological literature (Morris, Caruso, Buscot 
et al., 2014). This measure was originally introduced by Claude Shannon to quantify the 
entropy in strings of text (Shannon, 1948). It quantifies the uncertainty in predicting a 
species when randomly choosing a species from a dataset with multiple species. If pi 
represents the proportion of species i in the dataset of interest, then the Shannon index is 
computed as follows. 
𝐻′ = −� 𝑝𝑖ln𝑝𝑖𝑅
𝑖=1
= −� ln𝑝𝑖𝑝𝑖𝑅
𝑖=1
= ln
⎝
⎛ 1
� 𝑝𝑖
𝑝𝑖
𝑅
𝑖=1 ⎠
⎞ 
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Since pi represents the proportion of species in a dataset, the sum of the pi values equals 
unity by definition and hence the denominator in the above equation equals the weighted 
geometric mean of the pi values, with the pi values themselves being used as the weights 
(exponents in the equation). Shannon entropy is a standard measure of entropy / 
heterogeneity that works well with discrete data. This index ranges from 0 (when there is 
only one species) to infinity when there are a lot of species with high alpha diversity.  
Simpson Index: 
Edward H. Simpson introduced Simpson index first in 1949 when measuring the degree 
of concentration when individuals are classified into types (Simpson, 1949). The measure 
is equal to the probability that two entities taken at random from a dataset represents the 
same type. It is given by the following equation: 
𝜆 = � 𝑝𝑖2𝑅
𝑖=1
 
This is also equal to the weighted arithmetic mean of the proportions pi, with the 
proportional values pi  themselves being used as the weights. This index ranges from 0 
when there are a lot of species with high alpha diversity to 1 (when there is only one 
species). There is also a variation of this index called Gini–Simpson index (Jost, 2006), 
which is equal to 1 – λ.  The Gini–Simpson index equals the probability that the two 
entities taken at random from a dataset represent different types.  
Inverse Simpson Index: 
This index is simply the inverse of the Simpson index (Zhou, Xia, Treves et al., 2002) 
given by the following: 
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1/𝜆 = 1
� 𝑝𝑖
2𝑅
𝑖=1
 
This is equal to the average number of entities when the weighted arithmetic mean is 
used to quantify the average proportional abundance of entities in a dataset. This index 
ranges from 0 (when there is only one species) to infinity when there are a lot of species 
with high alpha diversity.  
 
Beta Diversity 
PathoStat has a module to display the beta diversity across samples based on Bray–Curtis 
dissimilarity and Weighted Unifrac measures. 
 
Bray–Curtis dissimilarity: 
J. Roger Bray and John T. Curtis introduced the Bray–Curtis dissimilarity statistic (Bray 
& Curtis, 1957), which is used to quantify the compositional dissimilarity between two 
different sites, based on counts at each site. Suppose if there are N number of sites and in 
our example datasets below, N number of samples, the statistic measure between two 
different sites/samples is given by the following equation: 
𝐵𝐶𝑖𝑗 = 1 − 2𝐶𝑖𝑗𝐴𝑖 + 𝐴𝑗 ; 𝐵, 𝑗 = 1𝑡𝑢 𝑁 
where Si  and Sj are the total number of specimens counted at both sites. Cij is the sum of 
the lesser values of the counts between the two sites for only those species in common 
between both sites. Suppose there are K species that are common between sites/samples i 
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and j, and the number of each of those species in site/sample i is Aik and number of those 
species in site/sample j is Bjk.  
𝐶𝑖𝑗 =  �min (𝐴𝑖𝑖,𝐵𝑗𝑖)𝐾
𝑖=1
 
The measure ranges from 0 (when the sites/samples are same with respect to the number 
of species and its counts) to 1 (when they are very diverse with nothing shared).  
Weighted Unifrac: 
Unifrac measure differs from Bray-Curtis dissimilarity in that it incorporates information 
on the relative relatedness (shared phylogenetic tree) of community members by 
incorporating phylogenetic distances between observed organisms in the computation 
(Lozupone, Hamady, Kelley et al., 2007).  Initially, a phylogenetic tree is constructed by 
placing all taxa found in one or both samples. A branch leading to taxa from both 
samples is marked as "shared" and branches leading to taxa which appears only in one 
sample are marked as "unshared". The Unifrac distance between the two samples is equal 
to the following: 
𝑡ℎ𝐵 𝑠𝑢𝑁 𝑢𝑓 "𝑢𝑢𝑠ℎ𝑎𝐵𝐵𝑎" 𝑏𝐵𝑎𝑢𝑠ℎ 𝐵𝐵𝑢𝑔𝑡ℎ𝑠
𝑡ℎ𝐵 𝑠𝑢𝑁 𝑢𝑓 𝑎𝐵𝐵 𝑡𝐵𝐵𝐵 𝑏𝐵𝑎𝑢𝑠ℎ 𝐵𝐵𝑢𝑔𝑡ℎ𝑠 (=  𝑠ℎ𝑎𝐵𝐵𝑎 + 𝑢𝑢𝑠ℎ𝑎𝐵𝐵𝑎) 
In weighted Unifrac measure, the branch lengths are weighted by the relative abundance 
of the lineages in the samples. This measure also ranges from 0 (nothing shared) to 1 
(everything shared). 
  
69 
Example datasets 
For our analysis, we have used two datasets: 1) Diet Study dataset and 2) Asthma 
study dataset.   
Diet Study dataset 
This is a dataset from a study performed in collaboration with Dr. Lichtenstein’s 
lab in Tufts University. In this diet study, there were 11 subjects with each person taking 
three different types of diets in random order. The three different types of diets were 
simple sugars, refined carbohydrates and unrefined carbohydrates. Each person took each 
of the diets in random order with one diet in the time period 0-5 weeks, and another diet 
in 8-13 weeks and another diet in 16-21 weeks. Samples from fecal matter were collected 
from each of the subjects for analysis at the end of each type of diets, which are at the end 
of 5 weeks, 13 weeks and 21 weeks. The sample characteristics are shown in Table 6 
below. We performed metagenomics analysis on 16SrDNA (Woo et al.) and RNA-Seq 
data (Conesa, Madrigal, Tarazona et al., 2016) on these samples to characterize the 
microbes in each of the samples and the variations of the abundance of the microbes 
among different types of samples. 
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    Sex Age TC LDL-C HDL-C VLDL-C TG 
Subject ID Diet   years mg/dL mg/dL mg/dL mg/dL mg/dL 
1 Simple F 71 233.0 146.0 48.3 38.7 193.3 
2 Simple F 78 206.3 124.7 48.7 33.0 167.7 
3 Simple F 64 220.3 133.7 76.0 10.7 55.0 
7 Simple M 60 158.3 89.3 36.0 33.0 166.0 
6 Simple F 67 258.0 170.3 56.3 31.3 159.3 
8 Simple M 57 160.0 93.0 32.3 34.7 174.0 
9 Simple F 77 191.0 114.0 48.3 28.7 146.0 
10 Simple M 57 184.7 113.0 45.7 26.0 132.0 
12 Simple M 58 286.7 174.3 58.3 54.0 272.0 
13 Simple F 62 183.3 110.3 45.7 27.3 139.0 
15 Simple F 64 235.0 149.0 64.0 22.0 113.5 
1 Refined F 71 237.0 151.3 51.3 34.3 174.7 
2 Refined F 78 203.3 126.0 48.3 29.0 147.7 
3 Refined F 64 204.7 125.7 65.7 13.3 67.7 
7 Refined M 60 192.3 107.7 35.0 49.7 250.3 
6 Refined F 67 272.3 176.3 60.7 35.3 179.3 
8 Refined M 57 198.0 127.0 38.0 33.0 165.0 
9 Refined F 77 185.3 105.0 45.3 35.0 176.7 
10 Refined M 57 189.3 119.3 45.0 30.3 154.0 
12 Refined M 58 275.3 172.7 48.3 54.3 273.3 
13 Refined F 62 221.3 139.0 58.7 23.7 121.3 
15 Refined F 64 227.7 148.3 59.3 20.0 101.3 
1 Unrefined F 71 248.3 159.7 49.7 39.0 196.3 
2 Unrefined F 78 184.3 107.0 48.0 29.3 149.3 
3 Unrefined F 64 204.7 126.0 67.0 11.7 60.3 
7 Unrefined M 60 167.3 86.7 32.7 48.0 241.0 
6 Unrefined F 67 266.7 170.3 63.7 32.7 166.0 
8 Unrefined M 57 174.3 117.3 31.0 26.0 133.0 
9 Unrefined F 77 178.0 105.3 43.7 29.0 147.7 
10 Unrefined M 57 200.7 119.0 48.0 33.7 169.3 
12 Unrefined M 58 251.7 166.0 54.7 31.0 156.3 
13 Unrefined F 62 156.0 88.3 42.3 25.3 127.7 
15 Unrefined F 64 213.7 134.3 63.0 16.3 83.3 
 
Table 6: Diet Study Sample Characteristics 
Shown here are the sample characteristics for the diet study dataset. TC: Total Cholesterol; LDL-C: LDL Cholesterol; HDL-C: HDL Cholesterol; VLDL-C: VLDL Cholesterol; TG: Triglycerides. 
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Asthma Study dataset 
This is a dataset from a study titled “Integrating microbial and host 
transcriptomics to characterize asthma-associated microbial communities” (Castro-
Nallar, Shen, Freishtat et al., 2015).  Samples from brushed nasal epithelial cells of 14 
children: 8 with asthma and 6 controls were obtained and RNA-Sequencing were 
performed on those samples. The RNA-Seq (Conesa et al., 2016) data collected from 
them was used for performing microbiome analysis to characterize the microbial 
variations between normal children and children with asthma. 
Visualization 
The first step in any statistical analysis starts with the summary measures and 
proper visualization of the measures. We have used various statistical measures such as 
alpha and beta diversity measures in the context of analyzing sequencing data to develop 
a pipeline for appropriate visualization to characterize the microbiome variation under 
different sources of variations such as disease status or treatment differences or other 
covariates of interest within an organism or environment. 
PathoStat Shiny App R-Package 
We have developed an interactive Shiny app visualization module as part of the 
PathoStat package in the R statistical programming language. The purpose of this 
package is to perform statistical microbiome analysis on metagenomics results from 
sequencing data samples. In particular, it supports analyses on the PathoScope generated 
report files. PathoStat provides various functionalities including relative abundance 
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charts, diversity estimates and plots, tests of differential abundance, multi-dimensional 
analysis including principal component and principal coordinate analysis, time Series 
visualization, and core OTU (Operational Taxonomic Unit) (Blaxter, Mann, Chapman et 
al., 2005) analysis. The important feature of the package is the interactive feature of all 
the plots, allowing the user to choose various parameters and variables of interest and 
visualize all the dynamically generated plots customized according to the user selected 
criteria.  
The Figure 11 below, shows the PathoStat relative abundance plot at the genus 
level for the samples from the diet study example 16SrDNA (Conesa et al., 2016) dataset 
that is included as part of the PathoStat R package.   
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Figure 11: PathoStat Relative Abundance plot at the genus level from the diet study 
example 16SrDNA dataset in PathoStat R package  
The Figure 12 below shows the PathoStat alpha diversity plots based on the three 
alpha diversity measures namely Shannon’s diversity index, Simpson index and Inverse 
Simpson index for the example dataset that is included as part of the PathoStat package. 
The Figure 13 below shows the PathoStat beta diversity plots using the default Bray–
Curtis dissimilarity measure. 
Shown here is the relative abundance plot of the microbes at the genus level for the 33 samples from the diet study example 16SrDNA dataset that is included as part of the PathoSat R package. The color and size of the bar in this plot is used to identify the genus and its relative abundance. 
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Figure 12: PathoStat Alpha Diversity plot for the diet study example 16SrDNA 
dataset that is included as part of the PathoSat R package   
Shown here is the alpha diversity plot based on the Shannon, Simpson and Inverse Simpson measures for the microbial relative abundance at the genus level for the 33 samples grouped by the types of diets (Refined, Simple and Unrefined) from the diet study example 16SrDNA dataset that is included as part of the PathoSat R package. For this example, we do not see any significant difference in alpha diversity between the three types of diets on all the three alpha diversity measures - Shannon, Simpson and Inverse Simpson measures.  
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Figure 13: PathoStat Beta Diversity plot for the diet study example 16SrDNA 
dataset that is included as part of the PathoSat R package   
Aim 2B 
Develop a module to calculate and display the confidence regions for the 
microbial relative abundance estimates and incorporate this module as part of the 
PathoStat toolkit for microbiome variation analysis. 
 
Shown here is the beta diversity plot based on the default Bray–Curtis dissimilarity measure between each pair of the 33 samples from the diet study example 16SrDNA dataset that is included as part of the PathoSat R package. For this example, we that the samples are clustered by subjects indicating that the difference in microbes between subjects is much more than the difference between diets.  
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Objective 
Develop a software pipeline to visualize the confidence regions of the 
microbiome variations along the dimensions selected by the user. By default it will show 
the 95% confidence region for the top two microbiomes that are present in the selected 
sample. 
 
Rationale 
When analyzing samples for microbial content using a metagenomics approach, it 
is often desirable to accurately characterize the relative abundance of pathogens and to 
determine the confidence level for these estimates. This will aid in both research and 
clinical contexts to develop more appropriate targeted therapies. Hence, a pipeline to 
display the confidence regions for the microbiome variation estimates will be helpful for 
physicians and researchers in developing personalized and targeted treatment plans based 
on this analysis. 
 
Experimental Plan 
Add to PathoStat pipeline a module for the display of confidence regions for the 
microbial relative abundance estimates for the microbes selected by the user. There will 
be an option to choose the microbes for each of the X and Y axis, for the display of 
confidence region along those components. Evaluate this module using real and 
simulated data examples.  
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Confidence Region Calculation 
We use the large sample multivariate distribution of the Maximum Likelihood 
Estimator (MLE) for the relative abundance estimates in the calculation of the confidence 
regions for the microbial proportions of the microbes chosen by the user.  
Let 𝑋 = (𝑋1,𝑋2, … ,𝑋𝑔) represent the counts for each of the g microbes in a sample. The 
relative abundance MLE estimates of the sample is given by ?̂? = (?̂?1, ?̂?2, … , ?̂?𝑔)  = 
1
∑�𝑋1,+ 𝑋2+ …+ 𝑋𝑔� �𝑋1,𝑋2, … ,𝑋𝑔� = �𝑋1𝑛 , 𝑋2𝑛 , … , 𝑋𝑔𝑛 � ;𝑢 = ∑(𝑋1 +  𝑋2 +  … +  𝑋𝑛).  
 
Fisher Information: 
In order to find the asymptotic distribution of an estimator, we use the Fisher 
Information, which is defined as follows:  
𝐼(𝜃) = −𝐸[ 𝜕2
𝜕2𝜃
log𝑓(𝑥,𝜃)] = 𝐸[( 𝜕
𝜕𝜃
log𝑓(𝑥,𝜃))2] = 𝑉[ 𝜕
𝜕𝜃
log𝑓(𝑥,𝜃)] 
 
For the MLE ?̂?, we have the following asymptotic approximation: 
?̂? ~ 𝑁�𝑝, 𝐼𝑛(?̂?)� ; 𝐼𝑛(?̂?) = 𝐹𝐵𝑠ℎ𝐵𝐵 𝐼𝑢𝑓𝑢𝐵𝑁𝑎𝑡𝐵𝑢𝑢 
 
For the multinomial distribution with 'g' number of events, Fisher Information is 
computed as follows: 
𝑓(𝑥, 𝑝) ∝  �𝑝𝑖𝑥𝑖𝑔
𝑖=1
;  �𝑝𝑖𝑔
𝑖=1
= 1 
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log�𝑓(𝑥,𝑝)� = 𝑠 +  �𝑥𝑖𝐵𝑢𝑔(𝑝𝑖)𝑔−1
𝑖=1
+ 𝑥𝑔𝐵𝑢𝑔 �1 − �𝑝1 + 𝑝2 + ⋯+ 𝑝𝑔−1�� 
∂
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−
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Confidence Regions: 
For the MLE ?̂?, we have the following: 
?̂? ~ 𝑁�𝑝, 𝐼𝑛(?̂?)�  
�𝐼𝑛(?̂?)�−1/2(𝑝 − ?̂?)  → �𝑍1,𝑍2, . .𝑍𝑔−1�;𝑍𝑖𝐵𝐵𝑎 ~𝑁(0,1); 𝐵 = 1, . . . ,𝑔 − 1 
From this we get the following: (𝑝 − ?̂?𝑛)′𝐼𝑛(?̂?𝑛)(𝑝 − ?̂?𝑛) →𝑑 𝜒𝑔−12  
We use this asymptotic approximation in our computation of the confidence region in 
terms of standard chi-square distribution with g-1 degrees of freedom. In the context of 
our problem, we use this to compute the confidence region for the relative abundance of 
the microbes in each of the samples. 
Suppose we are interested in the confidence interval of some linear scalar 
functions of the parameters of the form 𝑡′𝑝 , and estimated by 𝑡′?̂? . The confidence 
interval for linear scalar function of the estimator can be obtained in terms of the Fisher 
Information as follows: 
𝑡′?̂? ± 𝑍�𝑡′ �𝐼𝑛 �?̂?𝑛�−1� 𝑡 
 
Confidence Regions of the logit transformation: 
When the number of counts of microbes in a sample is small and also when the microbial 
relative abundance is small, the logit transformation of the proportion gives a better 
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estimate of the confidence region.  We can compute the confidence region for the logit 
transformation of the proportion as follows using a method called delta-method.  
 
For an estimator 𝑋𝑛 of 𝜃 with √𝑢(𝑋𝑛 − 𝜃) → 𝑁(0,𝜎2), if we want to find an estimator 
for 𝑔(𝜃), we get the following using delta-method: 
 √𝑢(𝑔(𝑋𝑛) − 𝑔(𝜃)) → 𝑁�0,𝜎2�𝑔′(𝜃)�2�. 
For a logit transformation g(p) = logit(p), we can compute 𝑔′(𝑝) =  1
𝑝(1−𝑝) 
For multivariate case, we get the following: 
�𝐼𝑛(?̂?)�1/2(𝑝 − ?̂?)  → �𝑍1,𝑍2, . .𝑍𝑔−1�;𝑍𝑖𝐵𝐵𝑎 ~𝑁(0,1); 𝐵 = 1, . . . ,𝑔 − 1 
�𝐼𝑛(?̂?)�12�𝐵𝑢𝑔𝐵𝑡(𝑝) − 𝐵𝑢𝑔𝐵𝑡(?̂?)�  → 𝑔′ �?̂?� �𝑍1,𝑍2, . .𝑍𝑔−1�; 
𝑍𝑖𝐵𝐵𝑎 ~𝑁(0,1); 𝐵 = 1, . . . ,𝑔 − 1 
where 𝑔′ �?̂?� =
⎝
⎜
⎜
⎜
⎜
⎜
⎜
⎜
⎜
⎛
1
𝑝1(1−𝑝1) 0 ⋯ 0
0 1
𝑝2(1−𝑝2) ⋯ 0
⋮ ⋮ ⋱ ⋮
0 0 ⋯ 1
𝑝𝑔−1�1−𝑝𝑔−1�⎠
⎟
⎟
⎟
⎟
⎟
⎟
⎟
⎟
⎞
;  ∑ 𝑝𝑖𝑔−1𝑖=1 < 1 
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From this, we get the following asymptotic approximation for the confidence region of 
the logit transformation in terms of standard chi-square distribution with g-1 degrees of 
freedom. 
(𝐺′(?̂?) ∗ (𝐵𝑢𝑔𝐵𝑡(𝑝) − 𝐵𝑢𝑔𝐵𝑡(?̂?)))′𝐼𝑛(?̂?𝑛)(𝐺′(?̂?) ∗ (𝐵𝑢𝑔𝐵𝑡(𝑝) − 𝐵𝑢𝑔𝐵𝑡(?̂?))) 𝑑→ 𝜒𝑔−12  
where 𝐺′(?̂?) =
⎝
⎜
⎜
⎜
⎜
⎜
⎜
⎜
⎛
𝑝1(1 − 𝑝1) 0 ⋯ 0
0 𝑝2(1 − 𝑝2) ⋯ 0
⋮ ⋮ ⋱ ⋮
0 0 ⋯ 𝑝𝑔−1(1 − 𝑝𝑔−1)⎠⎟
⎟
⎟
⎟
⎟
⎟
⎟
⎞
;  ∑ 𝑝𝑖𝑔−1𝑖=1 < 1 
 
Confidence Region Module: 
The confidence region module of the PathoStat software package will compute the 
confidence region of the microbial proportions using the methods described above. The 
multiple dimension confidence region is displayed by extracting the marginal distribution 
of two components at a time for displaying as a two dimensional graph with the user 
having the option to interactively choose the dimensions of interest. The boundary will be 
clearly marked for the user to infer the variability of the microbial composition based on 
the confidence regions that is displayed. This module is developed as a component of the 
interactive Shiny app for the PathoStat module.  A screenshot of this PathoStat 
confidence region module is shown in Figure 14 and a confidence region plot with 
inverse logit transformation is shown in Figure 15 below.  
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Figure 14: PathoStat Confidence Region module  
Shown here is the confidence region for relative abundance estimates of two microbes of one sample from the diet study example 16SrDNA dataset that is included as part of the PathoSat R package.  
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Figure 15: Low proportion 95% Confidence Region with Inverse Logit 
Transformation on a simulated data   
Aim 2C 
Perform differential abundance analysis of microbiomes under various conditions 
of interest and identify several multi-dimensional analysis that can be performed under 
the context of analyzing microbiome variations. 
Shown here is the confidence region for relative abundance estimates of two microbes of one sample with a low count of 300 total reads and microbial proportion estimate of 5% for the two microbes, computed using logit transformation and inverting it back to get it on the original proportion scale. 
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Objective 
Evaluate differential abundance analysis techniques using example datasets and 
identify different multi-dimensional analysis, which can be used to design modules that 
will be part of the PathoStat microbiome analysis toolkit and help with performing these 
type of analysis. 
Rationale 
In order to study the microbiome variations along the conditions of interest, it is 
important to perform multi-dimensional analysis and identify the variables of interest that 
are associated with the microbiome variations. We can also perform differential 
abundance analysis to statistically characterize the variations in the relative abundance of 
microbes with respect to the conditions of interest after accounting for other covariates.  
Experimental Plan 
Perform differential abundant analysis on the diet study example dataset with 
suitable model to capture the subject effect and the correlation structure induced by 
repeated measures on the subjects for multiple diets. Identify different types of multi-
dimensional analysis including principal component and principal coordinate analysis 
and incorporate those techniques into our PathoStat microbiome analysis toolkit.  
 
Differential Abundance Analysis 
We performed differential abundance analysis on the results of the metagenomics 
analysis on 16SrDNA and RNA-Seq data set from the diet study example mentioned 
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above. The results were consistent and there was not any statistically significant microbe 
that had a relative abundance which is differentially expressed across the three diets after 
accounting for multiple testing at the 0.05 significance level. The results from the 
16SrDNA data analysis are summarized in Table 7 below. 
We used linear mixed effects model for analysis with normal distribution 
assumption on the logit transformed relative abundance data with a random intercept for 
subject as random effect and including a correlation structure of compound symmetry 
among repeated measures by the same subject for different diets. After accounting for 
subjects using random effect as mentioned above, the following three genera 
(Coprococcus, Ruminococcus and Oscillospira) out of the total 21 genera that we tested, 
have a relative abundance that significantly varies across diets with p-values of 0.0207, 
0.0400 and 0.0457, and have at least a mean relative abundance of 1%. However, we do 
not find any genera that significantly varies across diets after adjusting for multiple 
testing using either Bonferroni method (Aickin & Gensler, 1996; Dunn, 1961) to 
maintain the familywise error rate (FWER) at a level of 0.05 or using Benjamini 
Hochberg method (Benjamini & Hochberg, 1995) to control False Discovery Rate (FDR) 
at a level of 0.05. Here, FWER is the probability of making at least one type I error in the 
family of all microbes that are compared for differential abundance and FDR is the 
proportion of false discoveries among the discoveries of differentially abundant 
microbes. We also performed analysis for differential abundance of microbes with 
respect to diets and included some covariates such as age and sex and we noted that there 
is no confounding of these covariates with the diet variable and hence we omitted those 
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covariates from our analysis. We also performed an analysis for variation of the relative 
abundance of the top differentially abundant microbes from the diet analysis with respect 
to LDL, HDL cholesterol level and Triglycerides (TG) level. We did not find any of 
those microbes significantly differentially abundant with respect to LDL and HDL 
cholesterol levels. We found that the relative abundance of Oscillospira significantly 
varies with respect to TG level after accounting for individual subjects through the 
random effects model described above, with a p-value of  0.0368 and the relative 
abundance is correlated with TG with a correlation (r) of (-0.5293). The relative 
abundance box plot for the top three genera is shown in Figure 16.   
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Coprococcus  
P-Value:  0.0207 Bonferroni Adjusted P-Value: 0.4342 
Relative Abundance 
Simple Refined Unrefined 
Mean 1.92% Mean 1.20% Mean 1.54% 
StdDev 1.20% StdDev 0.98% StdDev 0.74% 
Min 0.56% Min 0.18% Min 0.76% 
Max 4.69% Max 2.97% Max 2.87% 
            
Ruminococcus  
P-Value:  0.0400 Bonferroni Adjusted P-Value: 0.8402 
Relative Abundance 
Simple Refined Unrefined 
Mean 3.08% Mean 4.65% Mean 4.90% 
StdDev 2.85% StdDev 4.02% StdDev 4.17% 
Min 0.29% Min 0.18% Min 0.04% 
Max 10.99% Max 13.57% Max 12.20% 
            
Oscillospira  
P-Value:  0.0457 Bonferroni Adjusted P-Value: 0.9597 
Relative Abundance 
Simple Refined Unrefined 
Mean 1.38% Mean 1.58% Mean 1.10% 
StdDev 0.72% StdDev 0.95% StdDev 0.74% 
Min 0.37% Min 0.70% Min 0.37% 
Max 2.39% Max 3.53% Max 2.32%  
 
Table 7: Summary results from diet study 16SrDNA data 
 
Shown here is the summary results from the example diet study 16SrDNA data. Three genera (Coprococcus, Ruminococcus and Oscillospira) out of the total 21 genera that we tested, have a relative abundance that significantly varies across diets with p-values of 0.0207, 0.0400 and 0.0457, and have at least a mean relative abundance of 1%. However, we do not find any these genera significantly vary across diets after adjusting for multiple testing using either Bonferroni method or Benjamini Hochberg method. 
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Figure 16: Relative Abundance of top 3 genera of the Diet Study example   
Shown here is the box plot of the relative abundance of microbes grouped by diet types (simple, refined carbohydrates and unrefined carbohydrates) of top three genera (Coprococcus, Ruminococcus and Oscillospira) out of the total 21 genera that we tested, from the example diet study 16SrDNA data. 
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Multi-dimensional Analysis 
We have identified the following types of multi-dimensional analysis that can be 
performed in the context of analyzing microbiome data. 
Principal Component Analysis: 
Principal Component Analysis (PCA) (Jolliffe & Cadima, 2016; Pearson, 1901) is a 
statistical procedure that converts a set of observations which could be correlated into a 
set of linearly uncorrelated variables called principal components using an orthogonal 
transformation. The number of principal components is less than or equal to the number 
of original variables. This transformation is performed in such a way that the first 
principal component always has the largest possible variance accounting for as much of 
the variability in the data as possible, and each succeeding components account for the 
largest remaining variance and are also orthogonal to the preceding components.  
For a data X with p components, the transformation W using p vector of weights (𝑢1,𝑢2, … ,𝑢𝑝) is defined mathematically as follows.  
𝑇𝑛×𝑝 = 𝑋𝑛×𝑝𝑊𝑝×𝑝 
The transformation W is constructed in such a way that the individual variables of T 
considered over the data set successively inherit the maximum possible variance from X, 
with each weighting vector w constrained to be a unit vector.   
By keeping only the first L principal components, produced by using only the first 
L weighting vectors, we get the following truncated transformation. 
𝑇𝑛×𝐿 = 𝑋𝑛×𝑝𝑊𝑝×𝐿 
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We have also identified other multi-dimensional analysis namely Principal coordinates 
analysis (PCoA) (Pavoine, Dufour & Chessel, 2004) also known as metric 
multidimensional scaling and Non-metric multidimensional scaling (NMDS) (Levine, 
1977; McGee, 1968) that are useful in the context of microbiome variation analysis.   
    
Aim 2D 
Develop a software pipeline toolkit called PathoStat for microbiome variation 
analysis. 
Objective 
Incorporate the modules and techniques developed above into a complete toolkit 
for microbiome variation analysis.  
Rationale 
In order to perform microbiome variations analysis, a good toolkit is needed with 
rich set of visualization modules and statistically sound analysis modules. By 
incorporating all the modules mentioned in the aims above and designing a toolkit with 
easy extensibility, will be of great help to the scientific community in performing these 
types of analysis.  
Experimental Plan 
Develop a module for differential abundance analysis and present the results in a 
suitable format for easy visualization. Develop exploratory tree module where the relative 
abundance of microbes is presented in a taxonomic tree format with abundance level 
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differentiated based on conditions of interest. Develop interactive principal component 
analysis and principal coordinate analysis plots where the user can choose the principal 
components of interest. Develop a module to perform all the multi-dimensional analysis 
identified in the previous aim. Implement these modules into our PathoStat software tool, 
which will be an interactive software pipeline developed as a Shiny app R package.  
 
Exploratory Tree 
We have developed a module to show all the microbes in the samples in the form 
of a phylogenetic tree format. In Figure 17 below, the PathoStat exploratory tree plot with 
the relative abundance of the microbes at the genus level is shown for each of the 
samples. A circle drawn next to a microbe indicates a sample that has that microbe. The 
size of the circle represents the relative abundance of the microbe in that sample. The 
color of the circle represents the type of the sample and in this example represents one of 
the diet types: red for refined carbohydrates diet, green for simple diet and blue for 
unrefined carbohydrates diet. We can infer from this plot whether a microbe is present in 
a sample with a particular type of diet and whether the relative abundance of the microbe 
is higher or lower in a particular type of diet.  
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Figure 17: PathoStat Exploratory Tree for the diet study 16SrDNA dataset   
Shown here is the exploratory tree plot with the relative abundance of the microbes at the genus level for each of the samples. A circle drawn next to a microbe indicates a sample that has that microbe. The size of the circle represents the relative abundance of the microbe in that sample. The color of the circle represents the type of the sample and in this example represents one of the diet types: red for refined carbohydrates diet, green for simple diet and blue for unrefined carbohydrates diet. We can infer from this plot whether a microbe is present in a sample with a particular type of diet and whether the relative abundance of the microbe is higher or lower in a particular type of diet. 
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Differential Abundance 
We have developed a module to show the differential abundance of the microbes 
across the samples. Figure 18 below shows the differential abundance plot for the diet 
study example . Here, each bar corresponds to a sample and represents the abundance 
range of all the microbes in that sample. The color of the bar represents the type of the 
samples and in this example: blue represents refined carbohydrates, orange represents 
simple and green represents unrefined carbohydrates. It can be inferred that there is no 
significant visible differential abundance across the samples from the three types of diets. 
 
Figure 18: PathoStat differential abundance box plot for diet study example 
Shown here is the differential abundance plot for the diet study example. Here, each bar corresponds to a sample and represents the abundance range of all the microbes in that sample. The color of the bar represents the type of the samples and in this example: blue represents refined carbohydrates, orange represents simple and green represents unrefined carbohydrates. It can be inferred that there is no significant visible differential abundance across the samples from the three types of diets.  
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Multi-dimensional analysis using BiPlot 
We have developed a module to perform multi-dimensional analysis using BiPlot. In 
Figure 19 below, multi-dimensional analysis using non-metric multidimensional scaling 
(NMDS) method is shown for diet study example. BiPlot features both the microbes and 
samples in the same plot with options to choose different methods for calculating 
distances between them. The samples are colored and shaped here based on diet types. 
The label is shown for the microbes at the genus level. We can see that there is no 
clustering of samples based on diet types and the microbes are spread apart indicating 
that they are diverse.   
 
Figure 19: Multi-dimensional Analysis using BiPlot 
Shown here is the BiPlot which features both the microbes and samples in the same plot with options to choose different methods for calculating distances between them and non-metric multidimensional scaling NMDS option selected here. The samples are colored and shaped here based on diet types. The label is shown for the microbes at the genus level. We can see that there is no clustering of samples based on diet types and the microbes are spread apart indicating that they are diverse. 
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Principal Component Analysis  
We have developed a module to perform Principal Component Analysis (PCA). 
In Figure 20 below, the Principal Component Analysis (PCA) plot for asthma study 
dataset with the first and third principal components selected is shown. The samples are 
colored here based on the two types of sample conditions. We can see that there is 
clustering of samples based on whether the samples are from children with asthma or 
controls, indicating clear microbial diversity based on the sample conditions. This 
module also allows the user to interactively select any of the two principal components to 
analyze if there is any clustering of samples in any of the dimensions.  
 
Figure 20: PathoStat Principal Component Analysis plot for asthma study dataset 
Shown here is the Principal Component Analysis (PCA) plot for asthma study dataset with the first and third principal components selected. The samples are colored here based on the two types of sample conditions: blue represents asthma and orange represents controls. We can see that there is clustering of samples based on whether the samples are from children with asthma or controls, indicating clear microbial diversity based on the sample conditions.  
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Principal Coordinate Analysis  
We have developed a module to perform the Principal Coordinate Analysis 
(PCoA). In Figure 21 below, the PathoStat Principal Coordinate Analysis plot for asthma 
study dataset with the first two principal components selected is shown. The samples are 
colored here based on the two types of sample conditions. We can see that there is 
clustering of samples based on whether the samples are from children with asthma or 
controls, indicating clear microbial diversity based on the sample conditions. This 
module also allows the user to interactively select any of the two principal coordinates to 
analyze if there is any clustering of samples in any of the dimensions. 
 
Figure 21: PathoStat Principal Coordinate Analysis plot for asthma study dataset 
Shown here is the Principal Coordinate Analysis (PCoA) plot for asthma study dataset with the first two principal coordinates selected. The samples are colored here based on the two types of sample conditions: orange represents asthma and blue represents controls. We can see that there is clustering of samples based on whether the samples are from children with asthma or controls, indicating clear microbial diversity based on the sample conditions.  
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Conclusion 
We have developed a toolkit for microbiome variation analysis called PathoStat 
as a shiny app R-package. It is available for download from Bioconductor at 
http://bioconductor.org/packages/PathoStat. PathoStat provides a rich set of visualization 
modules. Some of the salient features are relative abundance charts, diversity estimates 
and plots, tests of differential abundance and multi-dimensional analysis including 
principal component and principal coordinate analysis. The important feature of the 
package is the interactive feature of all the plots, allowing the user to choose various 
parameters and variables of interest and visualize all the dynamically generated plots 
customized according to the user selected criteria. We have developed a methodology for 
computing confidence region for the relative abundance estimates of the microbes in a 
sample and a module for displaying it. We have performed differential abundance 
analysis on a diet study dataset and used that as an example for design and development 
of the PathoStat toolkit. The toolkit is structured so that new modules can be easily added 
in the future. We hope that you will find this toolkit very useful when you want to 
analyze microbiome data. 
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CHAPTER FOUR 
Project 3: Batch Effects Analysis 
Introduction 
When analyzing high dimensional data, non-biological experimental variation or 
“batch effects” confound the true associations between the conditions of interest and the 
outcome variable. As shown in the Figure 1 of the Nature Reviews Genetics article (Leek 
et al., 2010), batch effects exist even after normalization. Hence, unless the batch effects 
are identified and removed, any attempts for downstream analyses, such as network 
inference and estimation, will likely be error prone and may lead to false positive results. 
Furthermore, many batch adjustment approaches artificially induce a correlation structure 
in the batch adjusted data that can often exaggerate the significance of results (e.g. p-
values) or even introduce spurious relationships in the data. This motivates the need for a 
computational framework to systematically identifying batch effects. Here, the aim is to 
develop a tool called BatchQC that visually depicts aspects of high dimensional data and 
evaluates the extent to which batch effects impact the association between the conditions 
of interest. Broadly, the aims of this project are to do the following: A) Analyze the effect 
of correlation of the batch adjusted data and develop new techniques to account for 
correlation in two step hypothesis testing approach. B) Develop a software pipeline to 
identify whether batch effects are present in the data and adjust for batch effects in a 
suitable way. 
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Aim 3A 
Analyze the effect of correlation of the batch adjusted data and develop an 
appropriate workflow to account for correlation in two-step Hypothesis Testing approach. 
 
Objective 
Batch effects introduce bias and confounding into experiments when experimental 
designs are unbalanced. Batch adjustment using a linear model introduces correlation into 
the data values within each batch whether or not experimental covariates are included. 
For unbalanced designs this correlation structure can lead to exaggerated significance in 
downstream analyses. This problem can be avoided if batch effect is directly modeled 
into the downstream analyses, but this procedure can be a daunting task for the normal 
user when doing complex tasks. Also, the mean-only adjustment may not be sufficient 
because the batch effect may affect the mean, variance and higher order moments of the 
distribution of the data. The objective is to account for this correlation and develop better 
techniques for analysis of data in the presence of batch effects. 
 
Rationale 
It is common to have both known and unknown batch effects in sequencing and 
microarray expression data and it is automatically adjusted in many cases without the 
availability of original unadjusted data. However, when the expression data are adjusted 
for batch effects, unwanted correlation is introduced and can lead to exaggerated 
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significance in unbalanced designs. Even when the data are unadjusted, unless both the 
known and unknown batch effects are accounted for, analysis for differential expression 
with the conditions of interest will not be accurate. Batch effects can be modeled directly 
as a mixed effect model, but this procedure can be a daunting task for the normal user, 
who would prefer to first adjust for batch using tools designed for adjusting batch effects, 
especially when the batch effect affects the mean, variance and higher order moments of 
the distribution of the data. Hence, the new approaches and workflows to account for 
correlation when performing two-step hypothesis testing after adjusting for batch effects 
using tools designed for batch effects, will have profound applicability in the context of 
analyzing expression data. 
 
Experimental Plan 
Determine a way to represent the variance structure for multiple genes and 
correlated samples in the analysis. Estimate the covariance matrix and develop 
appropriate significance tests or procedures accounting for the correlation with respect to 
the differential expression analysis with conditions of interest.  
Example datasets 
For our analysis, we have used three datasets: 1) Bladder cancer, 2) Nitric oxide 
and 3) Oncogenic signature. 
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Bladder cancer dataset 
This is a dataset from the R package called bladderbatch (Leek, 2016) 
(http://bioconductor.org/packages/bladderbatch/). This package contains microarray gene 
expression data on 57 bladder samples from 5 batches and 3 conditions. The batch and 
condition are highly confounded in this data set making it a suitable data set for 
experimenting with batch effect analysis. The number of samples in each batch and 
condition of the data set is presented in the table below. The batch and condition are 
confounded with a standardized Pearson correlation coefficient of 0.89. 
  Batch 1 Batch 2 Batch 3 Batch 4 Batch 5 
Condition Biopsy 0 0 0 5 4 
Condition Cancer 11 14 0 0 15 
Condition Normal 0 4 4 0 0 
Table 8: Number of samples in each batch and condition of bladder cancer dataset  
 Nitric oxide dataset 
This dataset is described in this publication (Johnson, Li & Rabinovic, 2007).  
This dataset resulted from an oligonucleotide microarray (Affymetrix HG-U133A) 
experiment. This experiment was repeated at three different times or in three batches 
(totaling 12 samples). In this dataset the batch and condition are perfectly balanced and 
thus providing another example case of batch effect analysis. The number of samples in 
each batch and condition of the data set is presented in the table below. The batch and 
condition are perfectly balanced with a standardized Pearson correlation coefficient of 0. 
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  Batch 1 Batch 2 Batch 3 
Condition Control 0 1 1 1 
Condition Control 7 1 1 1 
Condition NO 0 1 1 1 
Condition NO 7 1 1 1 
Table 9: Number of samples in each batch and condition of nitric oxide dataset  
Oncogenic signature dataset 
This dataset consists of sequencing data captured from human mammary 
epithelial cells after activating key growth pathway genes (GEO accession GSE73628) 
(Manimaran, Selby, Okrah et al., 2016). The data consists of three batches and ten 
different conditions corresponding to control and activation of nine different pathways. 
The batch and condition are confounded in this data set and thus providing another 
example case of batch effect analysis. The number of samples in each batch and 
condition of the data set is presented in the table below. The batch and condition are 
confounded with a standardized Pearson correlation coefficient of 0.92. 
  Batch 1 Batch 2 Batch 3 
Condition 1 6 12 9 
Condition 2 6 0 0 
Condition 3 0 6 0 
Condition 4 0 6 0 
Condition 5 0 5 0 
Condition 6 0 6 0 
Condition 7 0 6 0 
Condition 8 0 0 9 
Condition 9 0 0 9 
Condition 10 0 0 9 
Table 10: Number of samples in each batch and condition of oncogenic signature 
dataset 
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Hypothesis Testing using simulated data 
We will use the bladder cancer dataset described above as a reference to simulate 
different samples without condition effect (null data) but with batch variations and 
analyze the effect of batch variation on the hypothesis testing for variation on the 
conditions of interest. This simulated data set will have the same number (n=57) and 
experimental design as the original bladder cancer data set, thus the null data will have 
the same batch and condition information. Only the expression data of those samples are 
modified using this simulated data with no condition effects (null data) but with batch 
effects. Based on this analysis the best approach for analyzing data in the presence of 
batch is selected. 
 
Analysis methods in the presence of batch 
There are broadly two types of analysis that can be performed in the presence of 
batch. They are one step analysis and two step analysis methods. In one step analysis, the 
batch analysis and the downstream analysis are performed in one step — batch is directly 
accounted for in the downstream model. In two step analysis, batch analysis and 
adjustment is performed in the first step to batch adjust the data and the downstream 
analysis is performed in the batch adjusted data in the second step.  
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One step analysis simulation 
Goal: Establish that when we perform differential expression analysis in one step by 
including batch as a covariate, the type I error rate is controlled at the significance level 
of the test, as expected. 
Method: Let y represent the measured expression data. In the one-step analysis, both the 
condition of interest and the batch effect covariates are adjusted for at the same time as 
follows: 
 
𝑦 =  𝑋1𝛽1  +  𝑋2𝛽2  + 𝛼0  +  𝐵 
𝑋1 ∶  𝐵𝐵𝑢𝐵𝑢𝑔𝐵𝑠𝑎𝐵 𝑠𝑢𝑢𝑎𝐵𝑡𝐵𝑢𝑢 𝑎𝐵𝑠𝐵𝑔𝑢;  
𝑋2:𝐵𝑎𝑡𝑠ℎ 𝐷𝐵𝑠𝐵𝑔𝑢 
Null Data simulated from standard normal distribution with variance 1 and means with 
no effect for the Biological condition of interest (𝛽1 = 0) and five batches with means 
equal to 0, 1, 2 , 3 and 4 respectively. 
Models Compared: 
𝑦 =  𝑋1𝛽1  +  𝑋2𝛽2  + 𝛼0  +  𝐵 
𝑦 =  𝑋2𝛽2  + 𝛼0  +  𝐵 
 
Result: 
The p-values distribution of one-step analysis with null data is shown in Figure 22 
below, which looks similar to a uniform distribution as expected for p-values to follow 
(Murdoch, Tsai & Adcock, 2008). We also ran 100 runs of the simulation and the mean 
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proportion of genes that were significant at 0.05 level were 0.0501 with a range of 0.0462 
to 0.0535, which is very close to the 0.05 level that is expected. 
Partial Correlation Test: 
We also performed partial correlation test for the differential expression of the expression 
data of genes with the conditions of interest after accounting for the batch covariate. The 
p-values distribution of one-step analysis with null data using partial correlation test is 
shown in Figure 23 below, which looks similar to a uniform distribution as expected as 
expected for p-values to follow. We also ran 100 runs of the simulation and the mean 
proportion of genes that were significant at 0.05 level were 0.0498 with a range of 0.0449 
to 0.0543, which is very close to the 0.05 level that is expected. 
Conclusion: 
One step differential expression analysis by including batch as a covariate or with a 
partial correlation test between expression data and conditions of interest while 
accounting for batch, maintains the type I error rate at the significance level of the test.  
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Figure 22: P-values distribution of one-step analysis with null data  
Shown here is the p-values distribution of one-step analysis with no condition effect (null) data. This looks similar to a uniform distribution as expected.  
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Figure 23: P-values distribution of one-step analysis with null data using partial 
correlation test  
Two-step analysis simulation 
Goal: Establish that there is a problem of “exaggerated significance” when we perform 
differential expression analysis on batch adjusted data in two-step. 
Shown here is the p-values distribution of one-step analysis with no condition effect (null) data using partial correlation test between expression data and condition while controlling for batch. This looks similar to an uniform distribution as expected.  
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Method: In the two-step analysis, the data is first adjusted for batch effect covariates (y*: 
batch adjusted data) and then a study is performed for association with respect to 
conditions of interest as follows: 
𝒚∗  =  𝒚 −  𝑿𝟐𝜷�𝟐 
Models Compared: 
𝑦∗  =  𝑋1𝛽1  + 𝛼0  +  𝐵 
𝑦∗  = 𝛼0  +  𝐵 
Result: 
The p-values distribution of two-step analysis with null data without including batch as a 
covariate is shown in Figure 24 below. We also ran 100 runs of the simulation and the 
mean proportion of genes that were significant at 0.05 level were 0.2866 with a range of 
0.2771 to 0.2936. Under the null hypothesis, the proportion of false positive tests is 
expected to be equal to the alpha significance level. With more p-values shifted to the 
lower end, we see this problem of “exaggerated significance”.  
Two-step Partial Correlation Test: 
We also performed partial correlation test for the differential expression of the batch 
adjusted expression data of genes with the conditions of interest after accounting for the 
batch covariate. The p-values distribution of two-step analysis with null data using partial 
correlation test is shown in Figure 25 below. We also ran 100 runs of the simulation and 
the mean proportion of genes that were significant at 0.05 level were 0.2094 with a range 
of 0.2028 to 0.2178.  With more p-values shifted to the lower end, we again see this 
problem of “exaggerated significance”.  
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Conclusion: 
Two step differential expression analysis by first adjusting for batch and then testing 
without batch as covariate or with a partial correlation test between the batch adjusted 
expression data and conditions of interest while accounting for batch, does not maintain 
the type I error rate at the significance level of the test when the number of cases and 
controls is unbalanced in each batch and we see exaggerated significance due to the 
unbalanced design and because the batch adjusted data is correlated with reduced degrees 
of freedom. 
  
110 
 
Figure 24: P-values distribution of two-step analysis with null data 
 
Shown here is the p-values distribution of two-step analysis on batch adjusted data with no condition effect (null) data. We expect to see uniform distribution for null data, but we see exaggerated significance here with more p-values at the lower end due to the unbalanced design and because the batch adjusted data is correlated with reduced degrees of freedom.  
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Figure 25: P-values distribution of two-step analysis with null data using partial 
correlation test 
 
Batch Adjusted Data: Correlated 
We will show that the batch adjusted data is correlated with the derivation for the 
distribution of the batch adjusted data. 
Shown here is the p-values distribution of two-step analysis using partial correlation test between expression data and condition while controlling for batch on batch adjusted data with no condition effect (null) data. We expect to see uniform distribution for null data, but we see exaggerated significance here with more p-values at the lower end due to the unbalanced design and because the batch adjusted data is correlated with reduced degrees of freedom.  
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Let us define the following notations. 
y: the original data  
y*: Batch adjusted data 
X2: Batch design matrix 
X1: Design matrix for conditions of interest 
I: Identity matrix 
Let 𝑦 = 𝑋𝛽 + 𝐵 and the samples in y are independent and identically distributed (i.i.d.). 
Let us partition the model into two components as follows: 
𝑋 =  [𝑋1 𝑋2] 
𝛽 = �𝛽1
𝛽2
� 
𝑦 =  [𝑋1 𝑋2] �𝛽1𝛽2� + 𝐵 
In order to find the least square estimate of 𝛽  given by ?̂? , we need to find 𝛽  that 
minimizes the distance (𝑦 − 𝑋𝛽)′(𝑦 − 𝑋𝛽). In order to minimize the distance, we need 
to partial differentiate w.r.t. 𝛽 and equate to 0. 
By doing that, we get the following: 
𝑋′�𝑦 − 𝑋?̂?� = 0 
By partitioning 𝑋 in to 𝑋1 𝑎𝑢𝑎 𝑋2, we get the following equations: 
𝑋1
′𝑋1?̂?1 + 𝑋1′𝑋2?̂?2 = 𝑋1′𝑦    (1) 
𝑋2
′𝑋1?̂?1 + 𝑋2′𝑋2?̂?2 = 𝑋2′𝑦    (2) 
From the first equation we get the following: 
?̂?1 = (𝑋1′𝑋1)−1𝑋1′�𝑦 − 𝑋2?̂?2� 
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We need to eliminate ?̂?1 from equation (2) in order to obtain ?̂?2. For this 
purpose, we first multiply equation (1) by 𝑋2
′𝑋1(𝑋1′𝑋1)−1 to get the following. 
𝑋2
′𝑋1?̂?1 +  𝑋2′𝑋1(𝑋1′𝑋1)−1𝑋1′𝑋2?̂?2 =  𝑋2′𝑋1(𝑋1′𝑋1)−1𝑋1′𝑦    (3) 
When the third equation is taken from the second equation, we get the following. (𝑋2′𝑋2 −  𝑋2′𝑋1(𝑋1′𝑋1)−1𝑋1′𝑋2)?̂?2 = 𝑋2′𝑦 − 𝑋2′𝑋1(𝑋1′𝑋1)−1𝑋1′𝑦    (4) 
Let us define the following: 
𝐻1 = 𝑋1(𝑋1′𝑋1)−1𝑋1′     (5) 
The fourth equation can be rewritten as follows. (𝑋2′(𝐼 − 𝐻1)𝑋2)?̂?2 = 𝑋2′(𝐼 − 𝐻1)𝑦    (6) 
From the above, we get the following. 
?̂?2 = (𝑋2′(𝐼 − 𝐻1)𝑋2)−1𝑋2′(𝐼 − 𝐻1)𝑦    (7) 
Let us define the following: 
𝐻12 = 𝑋2(𝑋2′(𝐼 − 𝐻1)𝑋2)−1𝑋2′(𝐼 − 𝐻1) 
The batch adjusted data is the following: 
𝑦∗ = 𝑦 − 𝑋2?̂?2 
𝑦∗ = 𝑦 − 𝑋2(𝑋2′(𝐼 − 𝐻1)𝑋2)−1𝑋2′(𝐼 − 𝐻1)𝑦 
𝑦∗ = (𝐼 − 𝐻12)𝑦  
If we assume 𝑦 ~ 𝑁(𝑋𝛽,𝜎2𝐼) with variance 𝜎2, then  
𝑦∗~𝑁(𝑋1𝛽1,𝜎2(𝐼 − 𝐻12)(𝐼 − 𝐻12)′). 
Thus we see that the batch adjusted data is correlated (as long as the batch design is 
unbalanced). 
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Because the batch adjusted data is correlated, we can use the correlation information 
present in the batch adjusted data to use it in all downstream analysis for accurate 
analysis of differential expression along the conditions of interest (X1). We will develop a 
two-step analysis approach that takes in to account the correlation of the data. 
 
Two-step analysis with batch as covariate 
Goal: Develop a two-step analysis method without the exaggerated significance problem 
we mentioned above, when we perform differential expression analysis on batch adjusted 
data in two steps. 
Method: Here, the data is first adjusted for batch effect covariates (y*: batch adjusted 
data) and then a study is performed for association with respect to conditions of interest 
and including batch as covariate as follows: 
𝒚∗  =  𝒚 −  𝑿𝟐𝜷�𝟐 
Models Compared: 
𝑦∗  =  𝑋1𝛽1  + 𝑋2𝛽2  + 𝛼0  +  𝐵 
𝑦∗  = 𝑋2𝛽2  + 𝛼0  +  𝐵 
Result: Once the batch is included as a covariate in the two-step analysis with batch 
adjusted data, the distribution of the p-values as shown in Figure 26, remains similar to a 
uniform distribution as expected with null data. We also ran 100 runs of the simulation 
and the mean proportion of genes that were significant at 0.05 level were 0.0501 with a 
range of 0.0462 to 0.0535, which is very close to the 0.05 level that is expected. 
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Conclusion: If we know the batch design of the batch adjusted data, then two-step 
analysis with batch as covariate maintains the type-I error rate at the given significance 
level.   
 
Figure 26: P-values distribution of two-step analysis with batch as covariate using 
no condition effect (null) data 
 
Shown here is the p-values distribution of two-step analysis with batch as covariate on batch adjusted data using no condition effect (null) data. This looks similar to an uniform distribution as expected.   
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Two-step analysis with correlation 
Goal: Develop a two-step analysis method without the exaggerated significance problem 
as mentioned above, when we perform differential expression analysis on batch adjusted 
data in two steps, for the case when batch design is not known. 
Method: In the two-step analysis, the data is first adjusted for batch effect covariates (y*: 
batch adjusted data) and then a study is performed for association with respect to 
conditions of interest with estimated correlation. Here the covariance matrix (𝛴 ) is 
estimated as the sample covariance of the batch adjusted expression data using the 
information from multiple genes. We then use the Generalized Least Squares method as 
follows: 
𝒚∗  =  𝒚 −  𝑿𝟐𝜷�𝟐 
Models Compared: 
𝑦∗  =  𝑋1𝛽1  + 𝛼0  +  𝐵 
𝑦∗  = 𝛼0  +  𝐵 
In the generalized least squares approach, first the covariance matrix (𝛴) is decomposed 
in to triangular matrices using Cholesky Decomposition (Dereniowski & Kubale, 2004) 
method and the transformed data and design matrices are used in the regular regression 
method as follows: 
𝛴 = 𝐴𝐴𝑇 
S is a triangular matrix here using the Choleski Decomposition. In the generalized least 
squares approach, solving 𝑦 = 𝑋𝛽 +  𝜀, reduces to the following: 
𝐴−1𝑦 = 𝐴−1𝑋𝛽 + 𝐴−1𝜀 
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𝑦′ = 𝑋′𝛽 +  𝜀′ 
One issue that has to be noted here is that the batch adjusted data is not full rank and 
hence the covariance matrix will not be positive definite for performing the above 
generalized least squares method. Hence, a reduced data matrix to make it full rank is 
needed to perform the above operation. 
 
Figure 27: P-values distribution of two-step with correlation analysis on null data 
 
Shown here is the p-values distribution of two-step analysis with correlation analysis on batch adjusted data using no condition effect (null) data. This looks similar to an uniform distribution as expected.   
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Result: 
We see that the distribution of p-values as shown in Figure 27 looks similar to a uniform 
distribution as expected for null data, when performing the two-step with correlation 
analysis as described above. We also ran 100 runs of the simulation and the mean 
proportion of genes that were significant at 0.05 level were 0.0509 with a range of 0.0478 
to 0.0545, which is very close to the 0.05 level that is expected.  
Conclusion: 
If we use correlation of the batch adjusted data in the two-step analysis,  the type-I error 
rate is maintained at the given significance level. This gives an effective way for solving 
the exaggerated significance problem that is introduced in the two-step approach even 
when the exact batch design is unknown, as long as we can estimate the correlation in the 
samples through multiple gene measurements.  
 
Multiple methods comparison 
Goal: Perform a thorough analysis of the batch effect exaggerated significance problem 
using three different datasets. Also analyze the performance by including batch as a 
covariate when adjusting for batch using ComBat (Johnson et al., 2007) and using 
LIMMA (Ritchie, Phipson, Wu et al., 2015) for differential expression analysis. 
Method: We repeated the same analysis mentioned above on three different datasets: 
Nitric Oxide data set, Bladder batch cancer data set  and Oncogenic signature data set. 
We used 50 runs of random simulated data with no condition effect (null data) for 
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differential expression analysis. We also tested the performance with combinations of 
ComBat for batch adjustment and using LIMMA for differential expression analysis.  
Results: We noticed that including batch as a covariate addresses the exaggerated 
significance problem directly as summarized in Table 11 below. We note here that when 
performing differential expression analysis on a random null data using LIMMA with 
batch as a covariate,  approximately 5% of the genes are significant at an alpha level of 
0.05  as expected and thus avoiding the exaggerated significance problem. When 
adjusting for batch using ComBat, we adjusted for both mean and variance differences in 
batch. In the simulated random data, there was no variance differences by batch included 
in the simulation. When performing differential expression analysis on a random null 
data using LIMMA with Batch as a covariate on batch adjustment using ComBat,  
approximately 8.6%, 6.2% and 5.5% of the genes are significant at an alpha level of 0.05 
for the three data sets Nitric Oxide, Bladder cancer and Oncogenic signature data sets 
respectively, with a slight exaggerated significance because of the additional adjustment 
on batch variances which was not there in the simulated data set.  
Conclusion: We conclude that for the users who prefer to first adjust for batch using 
tools designed for adjusting batch effects and conduct the differential expression analysis 
in two-step, we have presented a way to include batch as a covariate when the batch 
design is available, or estimate the covariance matrix and conducting the two-step 
analysis with correlation structure that effectively avoids the exaggerated significance 
problem.  
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  Proportion of Significant Genes (alpha = 0.05) 
Dataset 
LIMMA without 
Batch 
ComBat + 
LIMMA without 
Batch  
LIMMA+ 
Batch 
ComBat + 
LIMMA + Batch 
Nitric oxide 109/22,283 2,917/22,283 1,116/22,283 1,927/22,283 
  0.00487 0.131 0.05 0.086 
  (0.0039 - 0.00565) (0.126 - 0.138) (0.045 - 0.054) (0.0802 - 0.0919) 
Bladder  17,374/22,283 3,574/22,283   1,116/22,283   1,384/22,283   
cancer 0.78 0.16 0.05 0.062 
  (0.774 - 0.787) (0.155 - 0.166) (0.047 - 0.053) (0.058 - 0.066) 
Oncogenic  10,286/18,052 1,628/18,052 911/18,052 985/18,052  
signature 0.57 0.09 0.05 0.0546 
  (0.561 - 0.578) (0.085 - 0.095)  (0.047 - 0.055) (0.051 - 0.059)  
 
Table 11: Proportion of significant genes with different combination of batch 
adjustment using ComBat and differential expression analysis using LIMMA   
Shown here is the proportion and range of significant genes that are differentially expressed when performing analysis through combination of different methods including LIMMA for differential expression analysis and ComBat for batch adjustment with 50 runs of random simulated dataset. The proportion of genes expected to be differentially expressed at an alpha significance level of 0.05 is 5%. We note that in LIMMA with Batch as a covariate analysis,  approximately 5% of the genes are significant at an alpha level of 0.05  as expected and thus avoiding the exaggerated significance problem.   
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Aim 3B 
Develop a software pipeline to identify whether batch effects are present in the 
data and adjust for batch effects in a suitable way in collaboration with others by leading 
and providing major contribution to the design and development of the pipeline. 
 
Objective 
Develop a software pipeline to visualize the expression data and its variation 
along known and unknown batches. Determine whether batch effects exist and 
automatically adjust for batch effects in the appropriate way. Batch effects can be 
adjusted using either mean only batch adjustment method or both mean and variance 
batch adjustment method and optionally include higher moments. When adjusting for 
batch effects, whether parametric assumption for the underlying distribution of the 
expression can be made needs to be determined, and if not, a more general empirical 
distribution needs to be used for the given dataset. The best possible batch adjustment 
method will be chosen for the given data after determining whether batch effects need to 
be addressed in the dataset. 
 
Rationale 
It is often the case that sequencing/microarray samples need to be collected in 
multiple batches over time. There exist both known and unknown batches in these 
samples that unless properly adjusted for, can lead to bias in the downstream analysis. 
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There are several batch adjustment tools that are currently available, but none of them 
can a priori indicate whether batch adjustment need to be done, and also what is the best 
way to adjust for batch before proceeding with the analysis. The new software pipeline 
called BatchQC will address these issues with respect to batch effects. 
 
Experimental Plan 
Develop a software pipeline called BatchQC that will first summarize the data and 
display a boxplot of the expression data with samples colored by batch for easy 
visualization to look for batch effects. The report will have a heatmap of the expression 
for selected top differentially expressed genes and the samples colored by batch at the 
top, which will help in identifying patterns of differential gene expression with respect to 
batch. It will have a sample correlation heatmap to display the pairwise correlations 
between samples so that we can see whether samples from the same batch are correlated. 
The report will also have principal components plots with an option for the user to select 
the principal components and by default will display the top two principal components. 
The principal component plots will also be colored by batches so that the user can see 
whether there is any clustering based on batches. In addition, there will be some 
statistical test performed through linear regression of principal components with the batch 
variables to test whether the batch variables are significantly associated with the each of 
the principal components. Once whether batch adjustment needs to be performed is 
established through the help of the above tests and plots, the method to adjust for batch is 
determined by comparing the assumed distribution plots of the data from one batch to 
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another to see whether there are differences in mean, variance or higher order moments 
across batches.  
BatchQC shiny app R-package 
BatchQC is a user friendly interactive Shiny app R-package that is easy to install 
and use. It is available for R versions 3.3.0+ (and also requires pandoc 1.12.0+). The 
entry point of this interface is the function batchQC, which inputs the data matrix, batch 
variables, and conditions of interest and produces three output formats: R Shiny App 
interface in ‘interactive’ mode, an optional static html report, and an optional 
BatchQCout data object. The Shiny App interface then allows the user to interactively 
evaluate sample and batch effects, and run batch adjustment using the ComBat and SVA 
methods. The interface makes batch effect evaluation interactive and ‘hands-on’ and 
makes BatchQC accessible for users with diverse backgrounds. The html report and data 
object will allow BatchQC to be integrated into automated pipeline projects. BatchQC 
can be applied to multiple types of ‘-omics’ data that can be generated from multiple 
profiling platforms, including sequencing and microarrays. The tool can be applied to 
high-throughput data from multiple applications, including genomics, epigenomics, 
proteomics, and metabolomics, etc.  
 
Need for multiple batch effect metrics: The major advantage of BatchQC are the 
multiple evaluations available to identify and explore batch effects. These evaluations are 
important because datasets often successfully pass some diagnostic metrics, but then fail 
others. Using the first simulated dataset included in the package, batch differences were 
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clearly seen in the boxplots and the Principal Components Analysis (PCA) analysis. 
However, using the second simulated dataset, PCA did not reveal these batch differences, 
while the boxplot and heatmaps did show batch differences. Also, using a real data 
example included in the package, batch differences were not seen in the boxplots and 
heatmaps, but the PCA analysis identified strong batch effects. The batch effects in these 
datasets indicate that different metrics are frequently needed for batch diagnostics in 
different datasets, and that multiple diagnostics can help the researcher efficiently 
develop a batch adjustment strategy in each individual case. 
Analysis 
BatchQC begins with a Summary tab that provides Confounding, Variation Analysis and 
P-value Analysis subtabs. The Confounding subtab provides a summary table of the 
experimental design and displays the number of samples in each batch and condition. In 
addition, it provides the standardized Pearson Correlation Coefficient and Cramer's V 
Confounding Coefficient that measure the level of confounding in the experimental 
design between batch and condition of interest. Because the simulated data comes from a 
balanced experimental design (e.g. no batch/condition confounding), the Standardized 
Pearson Correlation Coefficient and Cramer's V Confounding Coefficient are both 0—
correctly illustrating that there is no confounding between batch and condition. In 
contrast, in the signature dataset these coefficients are 0.92 and 0.80, due to the fact that 
the batches do not share any experimental conditions in common except for the control 
samples. This indicates that failure to remove batch effects in the signature data could 
potentially lead to significant confounding in downstream analyses (e.g. differential 
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expression) due to batch variation. In contrast, removing the batch effects in the 
simulated data is likely to be less important since the balanced design leads to 
independence between the batch and condition variables. 
 
The Variation Analysis subtab presents the percentage variation explained by full 
(condition + batch), condition and batch across the genes as a box plot and table. In 
Figure 28 and Figure 29, the percentage variation explained by batch in both datasets is 
greater than the average percent of variation explained by condition. Because the batch 
effect variation is larger than the experimental/condition variation, there is a clear need 
for batch adjustment in these data. The P-value Analysis subtab shows the distributions of 
batch and condition effect p-values across genes. The distribution of Batch Effect p-
values in Figure 30, illustrate many genes with low p-values (more than expected by 
chance), indicating that there is a batch effect in the real data. The simulated dataset (not 
shown) shows an even more extreme need for batch adjustment based on this metric.  
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Figure 28: Variation explained by Batch and Condition for the simulated data: 
Huge variation explained by Batch than Condition 
 
Figure 29: Variation explained by Batch and Condition for the signature data: High 
overlap of variation explained by Condition and Batch  
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Figure 30: Distribution of batch effect p-value for the signature data: many more 
low p-values than expected by chance 
Differential Expression: In BatchQC, the interactive boxplots of the expression data 
enable the user to select whether to sort or color the samples by condition or batch, and 
the expression differences are easily identified. In the simulated data, after sorting by 
condition and coloring by batch, the box plot in Figure 31 clearly reveals the difference in 
mean and variance of the expression data across batches for each condition. BatchQC 
makes it easy to identify the effect of batch adjustment on the expression data. For the 
signature data, Figure 32 shows the expression data before and after batch adjustment 
using ComBat (which can be applied interactively using the “ComBat” tab). 
Interestingly, although the signature dataset shows only mild differences between batches 
removed by ComBat, other metrics (such as PCA) shown below provide a very different 
perspective (see Figure 39 below). 
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Figure 31:  Differential Expression of simulated dataset: Tooltip with Sample and 
Batch information as the user rolls the cursor over the plot 
 
    
Figure 32: Differential Expression of the signature data colored by batch before and 
after ComBat 
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Figure 33: Top Differentially Expressed Genes found by LIMMA for the simulated 
dataset 
 
Figure 34: Top Differentially Expressed Genes found by LIMMA after batch 
adjustment by Combat 
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BatchQC also performs differential expression analysis using LIMMA (5) and other 
methods to identify the top differentially expressed genes. BatchQC shows how the top 
differentially expressed genes are affected between (A) the unadjusted data, (B) after 
using batch as a covariate in a LIMMA model, or (C) after batch adjusting using ComBat 
or SVA. For the simulated data  (Figure 33), gene 37 is the most differentially expressed 
gene before adjusting for batch with a log fold change of 1806.27 and an adjusted p-value 
of 0.07. However, after adjusting for batch using ComBat as shown in Figure 34, the 
most differentially expressed gene is gene 47 with a log fold change of 1740.91 and an 
adjusted p-value < 0.01 which is highly significant at 0.05 level. Similarly, there are also 
differences seen in the lower order of genes after adjusting using ComBat. Large changes 
in differentially expressed gene lists (increased/decreased significance) are strong 
indicators that a batch effect exists in the data and that some level of batch correction is 
needed.    
Median Correlations  
Finding the similarity or dissimilarity between samples is often essential to determine 
whether to exclude some outlier samples or whether batch effects impact the differential 
expression analysis of the data. We use the median correlation, or the median of the 
pairwise correlation of each samples with the other samples. In BatchQC, the median 
correlation plot, colored by batch, can be used to deduce whether there are outlier 
samples and whether batch effects affect the median correlation of samples. The median 
correlation plot for the simulated data does not show any obvious outlier samples, but the 
median correlation plot for the signature data (Figure 35) shows that batch 1 has a median 
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correlation that is very different from the other batches, indicating a potentially strong 
batch effect.  
 
 
Figure 35: Median correlation plot of the signature dataset 
 
Heatmaps: Differential Expression Analysis 
Heatmaps are a useful way to visually determine if there is differential expression of data 
along the condition of interest. Batch effects can either mask the differential expression 
of the condition of interest or spuriously exhibit differential expression when it is not 
there. For the simulated data (Figure 36), we see clustering by batch in the original data 
but after adjusting for batch by ComBat, we see the clustering along the condition of 
interest. BatchQC also displays a sample correlation heatmap to identify whether samples 
are correlated with one another. There is no sample correlation that is of a concern for the 
simulated dataset.  
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Figure 36: Expression Heatmap of simulated dataset before and after ComBat 
Circular Dendrogram 
A Circular Dendrogram provides another way to cluster samples in a circular fashion for 
easy identification of clustering based on batch and condition effects. BatchQC provides 
an option to display a Circular Dendrogram after batch adjustment using either ComBat 
or SVA methods. For the signature dataset (Figure 37), the samples are clustered 
perfectly by batch, but after batch adjustment using ComBat, the samples are clustered 
perfectly by condition (Figure 38). A similar result is also seen after batch adjustment 
using SVA. In the signature dataset, the circular dendrogram clearly illustrates the batch 
effect before batch adjustment (Figure 37), and the condition effect after batch 
adjustment (Figure 38).  
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Figure 37: Circular Dendrogram for Signature dataset colored by batch 
 
Figure 38: Circular Dendrogram for Signature dataset colored by condition after 
ComBat 
PCA Analysis 
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Principal Components Analysis (PCA) is frequently used to cluster samples and identify 
batch effects. BatchQC provides an option to select a principal component for the x-axis 
and another for the y-axis, and displays the selected components for each samples. The 
scatter plot is colored by either batch or condition for the easy identification of clusters.  
BatchQC also provides an option to display the principal component scatter plot after 
batch adjustment using ComBat or SVA adjusted data. The before and after PCA 
visualization enables the user to see whether batch adjustment helps in removing 
clustering that may exist based on batch. For example in the signature dataset (Figure 39), 
the clustering is based on the batches. After batch adjustment using ComBat (Figure 40), 
the clustering is not based on the batches. The Explained Variation subtab has a table 
(Figure 41) that lists the percentage variation explained by batch and condition 
combinations for each of the top principal components. 
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Figure 39: PCA plot for signature dataset before batch adjustment 
 
Figure 40: PCA plot for signature dataset after batch adjustment using Combat 
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Figure 41: Principal Components Explained Variation for signature dataset 
Shape: Expression distribution shape analysis 
The shape analysis is used to identify the distribution shape of the batch variations of the 
expression data. Any distribution can be characterized by the mean, variance, and higher 
order moments. If batch effects exist, it is very useful to identify whether mean, variance 
or higher order moments vary between the batches. The subtab Batch Variation (Figure 
42) displays the mean, variance, skewness, and kurtosis of the expression distribution 
across genes for all of the samples. The batch effect variation for mean and variance is 
highly significant (p<0.0001), but Figure 43 illustrates that after batch adjustment using 
ComBat, the batch effect variations for the mean and variance are no longer significant, 
with gene-wise comparison p-values of 0.9999 and 0.7298, respectively.  
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Figure 42: Shape Batch Variation for simulated dataset 
 
Figure 43: Shape Batch Variation for simulated dataset after batch adjustment by 
Combat 
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ComBat: Batch Adjustment 
An advantageous feature of BatchQC is the ability to interactively apply the ComBat (1) 
batch adjustment approach to the data. The user can compare the ComBat adjusted data 
with the raw data in all of the diagnostics mentioned above after performing the batch 
adjustment by clicking the ‘Run ComBat’ button. In addition, this tab contains subtabs to 
evaluate the optimal ComBat parameter values for adjusting the data. Under the ComBat 
Plots subtab, the distributions of the mean and variance of the batch effects for the 
selected batch are plotted under the ComBat parametric curve assumption as well as an 
empirical distribution. Under the parametric curve assumption, ComBat assumes that the 
mean follows a normal distribution and variance follows an inverse gamma distribution. 
The density curves and Q-Q plots comparing the normal parametric assumption with the 
empirical distribution curve helps to decide which batch adjustment is most suitable for 
the given data. In Figure 44, the density and QQ plots on the top correspond to the batch 
mean and the bottom plots correspond to the batch variance, and since the parametric and 
non-parametric curves are not very different, the parametric assumption is sufficient for 
the simulated dataset. There is also a summary measure of this comparison of curves 
using a formal Kolmogorov-Smirnov test listed under the Summary subtab, and we see 
that for the simulated dataset the p-value is not significant, implying parametric 
assumption is sufficient.  
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Figure 44: ComBat diagnostics plots for the simulated dataset 
SVA: Surrogate Variable Analysis 
BatchQC also allows the user to apply Surrogate Variable Analysis (SVA) (2) to account 
for both known and unknown batch variables. BatchQC automatically uses a 
permutation-based approach to estimate the number of surrogate variables found in the 
data under the Summary subtab. As with ComBat, there is a ‘Run SVA’ button with an 
option to choose between the Regression Adjusted (default) and Frozen SVA options. 
After SVA is completed, the user can compare the SVA adjusted data with the raw and 
ComBat data under all of the diagnostic tabs discussed above. 
 
Conclusion 
When performing multi-dimensional and differential expression analysis using 
genomic data, often times they are affected by technical variation attributable to both 
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observed and unobserved factors (Leek et al., 2010). Hence, batch effect is an important 
factor in the analysis of genomic data. When conducting genomic data analysis in two-
step by first adjusting for batch using batch adjustment tools and proceeding with the 
downstream analysis often leads to an exaggerated significance problem. We developed 
an approach where the user can first use tools such as ComBat for batch adjustment and 
perform differential expression analysis in two-step and yet avoid the exaggerated 
significance problem. We have developed a toolkit called BatchQC that can help to 
identify whether batch effects are present in the data and adjust for batch effects in a 
suitable way. BatchQC is available for download as a shiny app R-package from 
Bioconductor at http://bioconductor.org/packages/BatchQC/. We hope you find this 
toolkit very useful when you are analyzing your data for batch effects. 
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CHAPTER FIVE 
Conclusion 
We have described three projects here, which together provide a complete set of 
toolkits and methodology necessary for analysis of genomic data for these applications. 
In the first project, we introduced methods and software for complete metagenomic 
analysis. We developed a complete software pipeline called PathoScope to identify 
microbes and pathogens to the strain level using a Bayesian mixture model with a 
modified pseudo likelihood model. We evaluated the accuracy of the Bayesian mixture 
modeling approach in comparison to other methods and also evaluated how prior 
information in the Bayesian mixture modeling improves these estimates. We performed a 
simulation study to evaluate the read coverage needed to estimate pathogen proportions 
to a given confidence limit. Based on this study, we recommend that for single strain 
identification, about 0.1X coverage of reads is sufficient to get more than 99% accuracy 
using PathoScope. PathoScope 2.0 is available as a python module for download from the 
sourceforge at https://sourceforge.net/projects/pathoscope/. 
In the second project, we introduced a toolkit for microbiome variation analysis 
called PathoStat. We have developed a methodology for computing confidence region for 
the relative abundance estimates of the microbes in a sample and a module for displaying 
it. We have performed differential abundance analysis on a diet study dataset and used 
that as an example for design and development of the PathoStat toolkit. PathoStat 
provides a rich set of visualization modules. Some of the salient features are relative 
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abundance charts, diversity estimates and plots, tests of differential abundance and multi-
dimensional analysis including principal component and principal coordinate analysis. 
The important feature of the package is the interactive feature of all the plots, allowing 
the user to choose various parameters and variables of interest and visualize all the 
dynamically generated plots customized according to the user selected criteria. The 
toolkit is structured so that new modules can be easily added in the future. PathoStat is 
developed as a shiny app R-package and is available for download from Bioconductor at 
http://bioconductor.org/packages/PathoStat. We hope that you will find this toolkit very 
useful when you want to analyze microbiome data. 
When performing multi-dimensional and differential expression analysis using 
genomic data, often times they are affected by technical variation attributable to both 
observed and unobserved factors (Leek et al., 2010). We developed an approach where 
the user can first use tools such as ComBat for batch adjustment and perform differential 
expression analysis in two-step and yet avoid the exaggerated significance problem. We 
have developed a toolkit called BatchQC that can help to identify whether batch effects 
are present in the data and adjust for batch effects in a suitable way. BatchQC is available 
for download as a shiny app R-package from Bioconductor at 
http://bioconductor.org/packages/BatchQC/. We hope you find this toolkit very useful 
when you are analyzing your data for batch effects. 
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APPENDIX  
PathoScope2 Design 
PathoLib 
PathoLib prepares the target, host and other genome reference libraries of interest 
from the complete NT fasta file. The user inputs the taxonomy ids of interest and the 
PathoLib module creates a target fasta file corresponding to the given taxonomy ids from 
the NT fasta file. 
Flowchart 
 
 
Taxonomy appended nt_ti.fa format: ti|<taxonomy id>|org|<organism name of the taxonomy id>|[gi|...same as in original fasta] 
 
Dependency 
pathoscope.utils.seqParse 
pathoscope.utils.pathoUtils 
pathoscope.pathodb.dbUtils 
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Inputs: 
Case 1: DB User information provided 
Required: 
1. DB 
2. DB Host 
3. DB User 
4. DB Passwd 
5. NT file (downloaded from ftp://ftp.ncbi.nih.gov/blast/db/FASTA/nt.gz) 
6. Output prefix for target 
Optional: 
1. DB Port (default 3306)  
2. Taxon ids (Restrict to the give taxon ids) 
3. Subtax flag (When present will include all taxonomy ids in the tree that comes 
under the list of taxon ids given above. 
4. inputArgs.lib_nodesc (No description text will be appended in the fasta file that is 
created) 
Outputs: 
1. *-ti_val.fa  
2. *-ti_inval.fa 
Example command-line to create nt_ti_val.fa and nt_ti_inval.fa: 
pathoscope.py LIB -g /home/mani/work/data/nt_database/nt -dbhost localhost -dbuser 
pathoscope -dbpasswd johnsonlab -db pathodb -o nt 
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Case 2: DB User information not provided 
Required: 
1. NT file appended with ti information through the above case (nt_ti_val.fa) 
2. Output prefix for target 
Optional: 
1. Taxon ids (Restrict to the give taxon ids) 
2. Subtax flag (When present will include all taxonomy ids in the tree that comes 
under the list of taxon ids given above. 
3. inputArgs.lib_nodesc (No description text will be appended in the fasta file that is 
created) 
Outputs:  
1. *-ti_val.fa  
2. *-ti_inval.fa 
Example command-line option to create a reference library: 
pathoscope.py LIB -g 
/protected/projects/johnsonlab/data/innocentive_meta/nt_database/nt_ti_val.fa -t 7157 --
subtax -o mosquitos 
 
Python functions: 
pathoLib.append_ti_into_fasta_app(() 
Input: 
inputArgs.lib_reference, 
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taxon_ids,  
inputArgs.lib_subtax, 
MysqlConf,  
not(inputArgs.lib_nodesc), 
inputArgs.lib_online_search,  
inputArgs.lib_outprefix 
Output: 
*-ti_val.fa  
*-ti_inval.fa 
 
 
PathoMap 
PathoMap performs the alignment through wrappers for each type of aligners. It 
chooses the proper alignment parameters for the given input read fastq file taking into 
consideration the sequencing platform. It also splits the reference file into smaller files 
and combines the result at the end, if it exceeds the indexing limit of the aligner. 
Currently, there is a wrapper that is developed for Bowtie2 and wrappers for other 
aligners can be developed similarly later. PathoMap also performs the filtering from the 
target alignment file, all those reads that map to the filter alignment file. The result is one 
filtered alignment file that can be given as input to PathoID for processing. 
 
Flowchart 
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Dependency: 
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pathoscope.utils.pathoUtils 
Inputs: 
Required: 
1. Target lib fasta 
2. Input Read File (Fastq - single/paired end) 
Optional: 
1. Filter lib fasta 
2. Bowtie2 params for Target Lib 
3. Bowtie2 params for Filter Lib 
Outputs: 
Required: 
1. Filtered Alignment file 
Optional: 
1. Keep Intermediate Split and Alignment Index Files 
 
PathoID 
PathoID takes as input an alignment file in sam/blast(bl8)/gnu-sam format, which 
may or may not have the reference ID appended with taxon id, and produces an updated 
alignment file and a report with organism rankings in a Tab Separated Value Format 
(TSV) that can be opened in Excel. When the taxon id (ti) information is present, 
pathoscope will group together based on the ti and run the pathoscope reassignment 
algorithm to produce the results. 
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Flowchart 
 
 
Dependency: 
pathoscope.utils.pathoUtils 
Inputs: 
Required: 
1. Alignment file path 
Optional: 
1. Alignment file format (sam/bl8/gnu-sam) 
2. Output directory (where the report and updated alignment file is generated) 
3. Experiment tag (File prefix for the report and other files that are generated for 
easy identification) 
4. EM Algorithm maximum iterations 
5. EM Algorithm Epsilon cutoff 
6. Score Cutoff (Minimum alignment score required below which the alignment 
record will be dropped) 
7. Output alignment matrix flag (When present outputs *-genomeId.txt and *-
readId.txt files) 
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Outputs: 
Required: 
1. TSV (Tab Separated Value) report; *-report.tsv file 
2. Initial and Final Guess files; *-initGuess.txt, *-finGuess.txt files 
Optional: 
1. Updated alignment file; updated_<alignment file> 
2. Output alignment matrix files; *-genomeId.txt and *-readId.txt files 
 
Example command-line option to run pathoid reassignment: 
pathoscope.py -verbose ID -t=sam -
f=/unprotected/projects/johnsonlab/exp/pathoscope2/mani/testset/mosquito/8_25_CTTG
TA_L001.sam -o -s=.01 -e=Mosq1 -
outdir=/unprotected/projects/johnsonlab/exp/pathoscope2/mani/testset/mosquito 
 
Python functions: 
PathoIdOptions: 
ali_file = ""  : Alignment File (Required) 
verbose = False : Verbose flag to print additional information during execution 
score_cutoff = 0.01 : Score cutoff below which the alignment record will not be 
included 
exp_tag = ""  : Experiment tag - Output file prefix for easy identification 
ali_format = "sam" : Alignment format (Default: sam) 
outdir = ""  : Output directory where reports and all output files are created 
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emEpsilon = 0.01  : EM Algorithm epsilon cutoff - the change below which the 
iteration stops 
maxIter = 50  : Maximum number of iterations to run EM algorithm 
out_matrix_flag = True : Creates *-genomeId.txt and *-readId.txt files, when True 
noalign = False : No updated alignment file will be created when this flag is set to 
True 
 
 
PathoID.pathoscope_reassign() 
Input: 
PathoIdOptions mentioned above 
Output: 
finalReport (tsv file) 
reAlignfile (updated alignment file) 
Returns: 
(finalReport, x2, x3, x4, x5, x1, x6, x7, x8, x9, x10, x11, reAlignfile) 
x2: Genome  
x3: Initial Guess  
x4: Initial Best Hit 
x5: Initial Best Hit Read Numbers 
x1: Final Guess 
x6: Final Best Hit 
x7: Final Best Hit Read Numbers 
x8: Initial High Confidence Hits 
  
152 
x9: Initial Low Confidence Hits 
x10: Final High Confidence Hits 
x11: Final Low Confidence Hits 
 
Functions called by PathoID.pathoscope_reassign(): 
 
PathoID.conv_align2GRmat() 
Finds the Genome Read alignment matrix from the given alignment file in the following 
format given in the output below. 
Input: 
ali_file  : Input alignment file 
scoreCutoff : Score cutoff below which the alignment record will not be included 
aliFormat : Alignment format (sam/gnu-sam/bl8) 
Output: 
U  : Unique Read Index to Genome Index hash mapping 
NU : Non-Unique Read Index to custom list hash mapping. The custom list 
has 3 components. The first one is a list of Genome Indices. The second 
one is a list of score (float) of the mapping. The third one is a list of 
normalized score in integer of the mapping. 
genomes : List of Genome Ids. 
reads  : List of Read Ids. 
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PathoID.pathoscope_em() 
Runs the PathoScope EM Algorithm and returns the result from the pathoscope EM 
Algorithm reassignment. 
Input: 
U  : Unique Read Index to Genome Index hash mapping 
NU : Non-Unique Read Index to custom list hash mapping. The custom list 
has 3 components. The first one is a list of Genome Indices. The second 
one is a list of score (float) of the mapping. The third one is a list of 
normalized score in integer of the mapping. 
genomes : List of Genome Ids. 
maxIter : Maximum number of iterations to run the EM Algorithm 
emEpsilon : EM Algorithm epsilon value to check for change and stop 
verbose : Flag to display verbose information of the execution steps 
Output: 
initPi, pi, theta, NU 
initPi  : Initial value of the genome proportions 
pi  : Final value of the genome proportions after reassignment.  
theta  : Final theta value of the EM algorithm. 
NU  : Updated NU after EM algorithm reassignment. 
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Pathoreport 
Flowchart 
 
Dependency: pathoscope.utils.samUtils pathoscope.pathodb.dbUtils  
Inputs: Required: 1. Alignment file path 2. mySQL Configuration Optional: 1. PathoID.pathoscope_reassign() return elements 2. PathoScope2 run parameters and other information to be included in the report 3. Output directory (where the XML report will be generated)  
Python functions: 
pathoreport.xmlReport.writePathoXML()  
Input: Alignment File mySQL Configuration output File name  
Output: XML Report   
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XML Report Specification:  <Organisms> [List of Organism] <Organism> <relativeAmount> <taxonomy> (including lineage information) <organismName> <genus> <species> <strain> <genes> <reads> <contigs>      
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• Market Driven Management MKTG 5115 (UConn) Grade: A 
• New Product & Innovation Management MKTG 5230 (UConn) Grade: A+ 
HONORS, INTERESTS & ACTIVITIES 
• Member of Mu Sigma Rho National Statistical Honor Society, Member of American 
Statistical Association (ASA), Member of Beta Gamma Sigma, Member of Golden 
Key International Honour Society, Member of IEEE (2000-Current) 
• Received Oral Presentation Award from BU Genome Science Institute for “BatchQC: 
Interactive software framework for evaluating sample and batch effects in genomic 
data”, GSI Research Symposium, November 10, 2015  
• Chess; Yoga; Ancient Scriptures 
MAJOR PROJECTS 
• PathoScope software in python for metagenomics analysis at Dr. Evan Johnson’s 
Lab – Lead software architect, Statistical analysis of data and development of 
complete metagenomics software package that takes next-generation sequencing 
reads from a mixture sample and predicts which genomes are present using a 
Bayesian statistical analysis framework. 
• PathoStat: A Comprehensive Toolkit for Microbiome Variation Analysis developed at 
Dr. Evan Johnson’s Lab – Lead software architect, Statistical analysis of data and 
development of a Shiny App R-package 
• BatchQC: interactive software for evaluating sample and batch effects in genomic 
data, Shiny App R-package developed at Dr. Evan Johnson’s Lab – Lead software 
architect, Statistical analysis of datasets including proteomics dataset   
• Generalized Linear Models to characterize the occurrence of clinical outcomes 
related to Inferior Vena Cava (IVC) injury 
• Analysis of microarray data from sickle-cell disease (SCD) anemic subjects with 
pulmonary hypertension (PHT+) and without pulmonary hypertension (PHT-) to find a 
biomarker using differentially expressed genes between the two groups. 
• Single-cell RNA-Seq Differential Expression Analysis using Bayesian modeling 
• Biomarker identification of gene set using longitudinal DNA methylation data for 
differential methylation level corresponding to different drug treatments of cancer 
• Genome-Wide Association Study (GWAS) with genotype association of Fasting 
Plasma Glucose (FPG) in the diagnosis of type 2 diabetes 
• Survival analyses of the association between smoking and Coronary Heart Disease 
(CHD) and overall survival 
• Co-Investigator and Project Lead of NRA (NASA Research Announcement) 
Project - “An Integrated Tool-Supported Framework for IVHM Monitoring, Control 
and Verification” in collaboration with Prof. Grigore Rosu, Formal Systems 
Laboratory, University of Illinois: Development of a Monitoring-Oriented Programming 
(MOP) plugin for TEAMS (Testability Engineering And Maintenance System) 
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software for monitoring IVHM (Integrated Vehicle Health Management) Systems. 
• Co-Investigator and Project Lead of US Air Force STTR Phase I Project – 
“Scalable Formal Methods for Distributed Systems” in collaboration with Prof. Grigore 
Rosu, Formal Systems Laboratory, University of Illinois: Development of algorithms 
for comparing models to help in the design of distributed systems. 
• Project Lead of US Navy SPAWAR SBIR Project “Automated Network Health 
Management” in collaboration with University of Connecticut, Lockheed Martin and 
Ridgetop Group Inc: Development of a complete Network Monitoring System for ship-
board networks. 
• NASA SBIR project “Automation of Health Management, Troubleshooting and 
Recovery in Lunar Outpost”: Automate a part of Verification and Validation (V&V) of 
procedures, Health Management and recovery decision support-related activities 
through QSI’s TEAMS-based approach. 
• NASA STTR project "System Health and Impact Assessment Environment 
Demonstrated on Advanced Diagnostic and Prognostic Testbed (ADAPT)": 
Integrating QSI’s software with ADAPT at NASA ARC (Ames Research Center). 
• Data analysis and Development of Web services for integrating third party 
applications with QSI’s TEAMS (Testability Engineering And Maintenance System) 
software suite  
• US Air Force SBIR Project “Active Bus Analysis and Failure Forecasting”: 
Monitoring, testing and analysis of aircraft busses - Used LabView for analysis. 
• M.Eng Master’s thesis titled “Better ways for matching XSL patterns”: Development of 
efficient Tree pattern matching algorithms and techniques. 
• Modeling the development of Viral Diseases as a system of differential equations and 
solving the system of differential equations through Numerical Techniques and Linear 
Programming Techniques. 
CONFERENCE PRESENTATION 
• 2016 Joint Statistical Meeting (JSM), Chicago: “BatchQC: Interactive software 
framework for evaluating sample and batch effects in genomic data”, Contributed 
Paper, Section on Statistics in Genetics and Genomics. 
• 2015 11th International Conference on Health Policy Statistics (ICHPS) - 
Providence, Rhode Island, “Pathoscope 2.0: Statistical and computational methods 
for accurate characterization of microbes in sequencing samples”, Contributed 
Presentation. 
• 2015 7th Annual Genome Science Institute (GSI) Research Symposium , 
“BatchQC: Interactive software framework for evaluating sample and batch effects in 
genomic data”, Graduate Speaker Award. 
• 2015 The 29th New England Statistical Symposium (NESS), University of 
Connecticut, “Pathoscope 2.0: Statistical and computational methods for accurate 
characterization of microbes in sequencing samples.” 
• 2014 Joint Statistical Meeting (JSM), Boston: “Statistical and computational 
methods for accurate characterization of microbes in clinical and environmental 
sequencing samples”, Biometrics Section, Track: Large Scale Hypothesis Testing 
Biomarker Evaluation  
POSTER PRESENTATION 
• 2016 8th Annual Genome Science Institute (GSI) Research Symposium , 
“PathoStat: A Comprehensive Toolkit for Microbiome Variation Analysis” 
• 2016 Evans Research Days Poster Session, “PathoStat: A Comprehensive Toolkit 
for Microbiome Variation Analysis” 
• 2016 Inaugural MIT-Harvard Symposium on Health & Ventures in the 
Microbiome, “Pathoscope 2.0: Statistical and computational methods for accurate 
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characterization of microbes in sequencing samples.” 
• 2016 Boston University Data Science (BUDS) Day, “BatchQC: Interactive software 
framework for evaluating sample and batch effects in genomic data” 
• 2015 Evans Research Days Poster Session, “BatchQC: Software pipeline to 
identify batch effects in sequencing and microarray data and adjust for it in the best 
possible way” 
• 2014 Fourth Annual Boston University (BU) Clinical & Translational Science 
Institute (CTSI) Translational Science Symposium - Research on Disparities in 
Health Care “Pathoscope 2.0: Statistical and computational methods for accurate 
characterization of microbes in sequencing samples” 
• 2014 Evans Research Days Poster Session, “Pathoscope 2.0: Statistical and 
computational methods for accurate characterization of microbes in sequencing 
samples” 
• 2014 The 28th New England Statistical Symposium (NESS), Harvard School of 
Public Health “Statistical and computational methods for accurate characterization of 
microbes in clinical and environmental sequencing samples 
• 2014 Tufts Clinical and Translational Science Institute (CTSI) Translational 
Research Day, “Pathoscope 2.0: Statistical and Computational Methods for Accurate 
Characterization of Microbes in Sequencing Samples” 
• 2014 6th Annual Genome Science Institute (GSI) Research Symposium , 
Pathoscope 2.0: Statistical and computational methods for accurate characterization 
of microbes in sequencing samples” 
• 2013 Evans Research Days Poster Session, “PathoScope: Methods for accurate 
identification and estimation of genome proportions in metagenomic samples” 
STATUS 
US Citizen 
 
 
 
